Earlier onset of cognitive deficits and an upregulated neuroinflammatory response in the chronic phase after stroke in obese mice by Lui, Austin
Boston University
OpenBU http://open.bu.edu
Theses & Dissertations Boston University Theses & Dissertations
2018
Earlier onset of cognitive deficits
and an upregulated
neuroinflammatory response in the
chronic phase after stroke in obese
mice
https://hdl.handle.net/2144/31240
Boston University
   
  
BOSTON UNIVERSITY 
 
SCHOOL OF MEDICINE 
 
 
 
 
 
Thesis 
 
 
 
 
 EARLIER ONSET OF COGNITIVE DEFICITS AND AN UPREGULATED 
NEUROINFLAMMATORY RESPONSE IN THE CHRONIC PHASE AFTER 
STROKE IN OBESE MICE   
 
 
 
 
by 
 
 
 
 
AUSTIN LUI 
 
B.S., University of California, Davis, 2015 
 
 
 
 
 
 
Submitted in partial fulfillment of the 
 
requirements for the degree of 
 
Master of Science 
 
2018  
   
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© 2018 by 
 AUSTIN LUI 
 All rights reserved  
   
  
Approved by 
 
 
 
 
First Reader   
 C. James McKnight, Ph.D. 
 Associate Professor of Physiology and Biophysics 
 
 
Second Reader   
 S. Marion Buckwalter, M.D, Ph.D. 
 Associate Professor of Neurology and Neurosurgery 
 
   
iv 
 
 
ACKNOWLEDGMENTS 
I would like to thank Marion Buckwalter, Todd Peterson, James McKnight, and the entire 
Buckwalter Laboratory for all the guidance and help given to me for my project. 
   
v 
 
 
EARLIER ONSET OF COGNITIVE DEFICITS AND AN UPREGULATED 
 NEUROINFLAMMATORY RESPONSE IN THE CHRONIC PHASE AFTER 
STROKE IN OBESE MICE 
AUSTIN LUI 
 
ABSTRACT 
Stroke is a neurovascular disease that frequently results in decreased motor and 
cognitive functioning. Obesity is a major risk factor associated with ischemic stroke and 
is thought to worsen the functional deficits observed after stroke. Previous findings from 
our laboratory suggest that worse motor deficits in obese animals may be a result from an 
exacerbated neuroinflammatory response. Most animal studies demonstrate an 
association between obesity and worse cognitive functioning after stroke. However, the 
mechanisms are not well studied. This study examines the neuroinflammatory response, 
ischemic brain tissue damage, and cognitive functioning in diet-induced obese mouse 
models during the chronic phase after ischemic stroke, defined as weeks after stroke. Our 
study found an earlier onset of cognitive deficits in obese mice after stroke compared to 
normal weight mice. We found no differences in the degree of brain damage in obese 
animals and normal weight animals 11 weeks after stroke, but observed higher levels of 
microgliosis in obese animals compared to normal weight animals. Due to the limitations 
of our study, additional studies should be done to assess the severity of cognitive deficits 
in obese animals compared to normal weight animals in the chronic phase after stroke. 
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Further studies also need to be done to confirm our findings regarding the microglial 
response and degree of ischemic brain damage during the chronic phase. 
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INTRODUCTION 
 
 Stroke is a neurological disease with high mortality and morbidity rates. In 2015, 
the stroke death rate was 73.3 deaths in every 100,000 stroke patients in the United States 
(Yang, 2017). It is the fifth leading cause of death in the United States and is globally the 
second most common cause of death (Benjamin et al., 2017). Each year, there are around 
800,000 occurrences of stroke worldwide in the United States (Benjamin et al., 2017). 
Stroke is also significantly detrimental to one’s quality of life; many stroke survivors 
suffer from long-term complications, including motor and cognitive deficits (Lawrence et 
al., 2001). Around 60% of stroke-survivors experience an impairment in manual 
dexterity, or the loss of the ability to perform coordinated and fine movements with their 
hands 6 months after stroke (Claflin, Krishnan, & Khot, 2015). Additionally, the 
percentage of stroke survivors suffering from post-stroke dementia can range anywhere 
from 20% to 80% depending on the country, the population and question, and the 
cognitive tests used for evaluation (Sun, Tan, & Yu, 2014).  
Stroke is the sudden death of brain tissue due to the lack of oxygen and can be 
broadly divided into two different types, ischemic stroke and hemorrhagic stroke. 
Hemorrhagic stroke occurs when there is a rupture in a blood vessel in the brain (Caplan, 
Kasner, & Dashe, 2017). It can be further subdivided into a intracerebral hemorrhage, 
bleeding within the brain tissue, or a subarachnoid hemorrhage, bleeding within the 
subarachnoid space (Caplan et al., 2017). On the other hand, ischemic stroke occurs due 
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to a lack of blood perfusion to the brain, which can be caused by different factors 
including thrombosis, embolism, lacunar infarction, or systemic hypoperfusion, and leads 
to neural tissue necrosis (Caplan et al., 2017; Giraldo, 2017). The middle cerebral artery 
(MCA) is one of the largest arteries in the brain and is the most common blood vessels 
involved in ischemic stroke (Slater, 2018). Hemorrhagic stroke is shown to have a higher 
mortality rate compared to ischemic stroke (Andersen, Olsen, Dehlendorff, & 
Kammersgaard, 2009). However, hemorrhagic stroke composes 32% of all strokes while 
ischemic stroke composes 68% (Caplan et al., 2017). There are many different non-
modifiable and modifiable risk factors associated with stroke that have been identified. 
Non-modifiable risk factors include genetic predisposition, aging, and ethnicity, while 
modifiable risk factors include hypertension, diabetes, lack of physical activity, smoking, 
and obesity. (Meschia et al., 2014) 
 
Obesity as an epidemic and risk factor for stroke 
 Obesity, defined as a body mass index (BMI) of 30 or higher, has been a rising 
global epidemic over the past three decades, during which the prevalence of obesity 
approximately doubled for adults between 1980 and 2008 (World Health Organization, 
2018a). In 2016 worldwide, 39% of people of at least 18 years of age are overweight 
(defined as having a BMI between 25 and 30) and 13% are obese (World Health 
Organization, 2018b). Obesity is currently still a major problem, as more than 2.8 million 
people worldwide die as a result of being overweight or obese every year (U.S 
Department of Health and Human Services, 2018). 
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People who are overweight or obese are more likely to have an ischemic stroke 
compared to those of normal weight (Guo et al., 2016; Mitchell et al., 2015; Strazzullo et 
al., 2010; Suk et al., 2003). In one meta-analysis, it was found that an overweight person 
is 1.22 times more likely than a person of normal weight to have an ischemic stroke, 
while an obese person is 1.64 more likely to have an ischemic stroke compared to a 
person of normal weight (Strazzullo et al., 2010). Another study demonstrates that people 
who are overweight in young adulthood are 1.36 times more likely than people of normal 
weight to have a stroke while those who are obese in young adulthood are 1.81 times 
more likely to have stroke compared to those of normal weight (Guo et al., 2016). 
 
Pathophysiology of obesity 
Adipose tissue was traditionally thought to act mostly as a storage site for 
triglycerides (Greenberg & Obin, 2006). However, the discovery that adipose tissue 
secretes different signaling proteins, particularly the discovery of leptin in 1994 (Y. 
Zhang et al., 1994), led researchers to conceptualize adipose tissue as an “endocrine 
organ” (Greenberg & Obin, 2006). There are more than 50 signaling proteins, including 
adipose-specific and non-specific proteins, known to be released from adipose tissue, 
which are collectively called adipokines (Trayhurn & Wood, 2004). Adipokines play 
functional roles in different physiological processes including appetite regulation, 
metabolism, angiogenesis, immunity, and inflammation (Trayhurn & Wood, 2004). For 
example, the adipokine leptin acts on leptin receptors in the hypothalamus, decreasing 
appetite and increasing energy expenditure (Halaas et al., 1995; Lee et al., 1996). Another 
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major adipokine released by adipocytes is adiponectin, which upregulates fatty acid 
oxidation in tissues such as skeletal muscles and increases insulin sensitivity (Fruebis et 
al., 2001; Yamauchi et al., 2001). 
 Besides adipocytes, adipose tissue consists of different cell types including 
fibroblasts and immune cells (Huh, Park, Ham, & Kim, 2014). The immune response 
consists of the innate immune response and the adaptive immune response. The innate 
immune system is the first to respond to infection or injury and consists of the rapid 
activation of immune cells such as macrophages, neutrophils, dendritic cells, mast cells 
and innate lymphoid cells (Abbas, Lichtman, & Pillai, 2016d). While the innate immune 
response is immediate, it only provides non-specific defense and responds to 
biomolecules generally shared by microbes called pathogen-associated molecular patterns 
(PAMPs) or biomolecules that are released by cells during cell death, called damage-
associated molecular patterns (DAMPs) (Abbas et al., 2016d). In contrast, the adaptive 
immune system activates more slowly but provides a more specific response. The 
adaptive immune system consists of B and T-cells, which develop to recognize and target 
specific antigens (Abbas, Lichtman, & Pillai, 2016e). It is important to note that the two 
components of the immune system are highly interactive with each other. For example, 
the innate dendritic cells and macrophages are also antigen-presenting cells (APCs), 
which are cells that possess and use a surface molecule called the major 
histocompatibility complex II (MHC-II) to activate T-cells and trigger them to adapt 
different phenotypes (Abbas, Lichtman, & Pillai, 2016a). 
 
 
 
 
 
5 
 
 
 A variety of studies confirm that obese adipose tissues adapt a pro-inflammatory 
phenotype. Obese adipose tissue exhibits an upregulation of tumor necrosis factor (TNF), 
interleukin-6 (IL-6), monocyte chemoattractant protein-1 (MCP-1), along with other pro-
inflammatory mediators, and importantly some of these contribute to metabolic 
pathologies including insulin insensitivity (Fried, Bunkin, & Greenberg, 1998; 
Hotamisligil, Shargill, & Spiegelman, 1993; Sartipy & Loskutoff, 2003). One study 
found that the number of macrophages is positively correlated with the size of adipocytes 
and the BMI of patients, likely due to the infiltration of circulating monocytes, which 
differentiate into macrophages within the adipose tissue (Weisberg et al., 2003). 
Increased secretion of MCP-1 along with other cytokines from adipocytes are responsible 
for this macrophage infiltration (Kanda et al., 2006). Macrophages that reside in adipose 
tissue also release pro-inflammatory mediators such as TNF, IL-6, and inducible nitric 
oxide synthase (iNOS) (Weisberg et al., 2003). Together, an increase in the number of 
macrophages and their differentiation into a more pro-inflammatory state leads to this 
chronic low-grade inflammation in the obese.  
The inflammasomes, a protein complex responsible for activating a pro-
inflammatory response, also play a role in obesity-induced inflammation. NOD-like 
receptor family pyrin domain containing 3 (NLRP3), a type of Nod-like receptor (NLR), 
activates caspase-1, which upregulates production of pro-inflammatory cytokines 
including interleukin-1β (IL-1β) (Abbas et al., 2016d). Studies found activation of 
NLRP3 and caspase-1 in obese adipose tissues, in association with increasing IL-1β and 
interleukin-18 (IL-18) production and secretion (Stienstra et al., 2010, 2011; 
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Vandanmagsar et al., 2011). Deletion of NLRP3 or caspase-1 in obese adipose tissue 
results in increased glucose transporter type 4 (GLUT-4) and adiponectin, which leads to 
increased insulin sensitivity (Stienstra et al., 2010). Furthermore, evidence shows that 
disruption of inflammasome activation results in reduced MCP-1 production from 
adipose tissue, reduced macrophage infiltration, decreased adipocyte size, and increased 
rates of fat oxidation (Stienstra et al., 2010, 2011). The transcription factor called nuclear 
factor kappa-light-chain-enhancer of activated B cells (NF-κB), is also involved in the 
obesity-induced inflammatory response. Interestingly, free fatty acids (FFAs) are able to 
act through toll-like receptor 4 (TLR-4) on macrophages and adipocytes, which then 
promotes NF-κB signaling, causing increased inflammation and decreased glucose 
tolerance (Shi et al., 2006). 
In contrast to obese adipose tissue, lean adipose tissue tends to exhibit an anti-
inflammatory phenotype. For example, the majority of the macrophage population in lean 
adipose tissue secretes anti-inflammatory cytokines such as IL-10, which helps improve 
insulin sensitivity (Lumeng, Bodzin, & Saltiel, 2007). It is known that the cytokines 
interleukin-13 (IL-13) and interleukin-4 (IL-4) trigger alternative activation of 
macrophages into this anti-inflammatory phenotype. While adipocytes themselves can 
secrete IL-13 and IL-4 (Kang et al., 2008), a study by Wu et al. (2011) found that the 
majority of IL-4 within the adipose tissue is secreted from eosinophils, a type of innate 
leukocyte (Wu et al., 2011). The secretion of interleukin-5 (IL-5), a cytokine released by 
innate lymphoid type 2 cells resident to adipose tissue, is one proposed signaling 
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mechanism of signaling to facilitate the infiltration of eosinophils into adipose tissue 
(Molofsky et al., 2013). 
In addition to the differences in number and phenotype of innate immune cells 
between obese and lean adipose tissue, there are also differences in the composition and 
phenotype of adaptive immune cells like T-lymphocytes, also known as T-cells. IL-4  
secreted by eosinophils can also cause T-cells to differentiate into T-helper type 2 (Th2) 
CD4+ cells, which can secrete additional IL-4 and IL-13, further inducing macrophages 
to adopt an anti-inflammatory phenotype (Abbas, Lichtman, & Pillai, 2016b). This may 
be one reason that lean visceral adipose tissue has a higher proportion of Th2 CD4+ cells 
compared to the proportion in obese visceral adipose tissue (S. Winer et al., 2009). The 
study by Winer et al. (2009) showed that the number of CD4+ Foxp3+ regulatory T-cells 
(Tregs), another subpopulation of T-cells which secretes IL-4, IL-10, and IL-13 
(Tiemessen et al., 2007), are increased in lean but not in obese adipose tissue, leading to 
an anti-inflammatory environment (S. Winer et al., 2009). This study also demonstrated 
that obese adipose tissue tends to have fewer CD4+ Foxp3+ Tregs than CD4+ T-helper 
type 1 (Th1) CD4+ cells (S. Winer et al., 2009). Th1 cells are a pro-inflammatory 
subtype of T-cells which release the interferon-γ (IFN-γ), a cytokine that activates a pro-
inflammatory macrophage response (Abbas et al., 2016b). There is also evidence that 
CD8+ cytotoxic T-cells contribute to the inflammatory response in obesity, as CD8+ 
cytotoxic T-cells are known to help activate macrophages (Abbas et al., 2016d). One 
study showed that CD8+ cytotoxic T-cells infiltrate adipose tissue in animals fed high-fat 
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diet (HFD) and that these cells recruit and activate infiltrating macrophages, ultimately 
contributing to insulin resistance (Nishimura et al., 2009). 
In addition to T-cells, B-lymphocytes, also called B-cells, are a type of adaptive 
immune cell shown to modulate the inflammatory phenotype in adipose tissue. A study 
by Winer et al. (2011) shows that B-lymphocytes infiltrate into adipose tissue following 
diet-induced obesity and undergo isotype switching to produce pathogenic 
immunoglobulin Gs (IgGs), which causes macrophages within adipose tissue to secrete 
TNF through a mechanism involving the fragment crystallizable region of 
immunoglobulins (D. A. Winer et al., 2011). Interestingly, this study also suggests that 
B-cells activate T cells in a major histocompatibility complex-dependent manner, 
possibly allowing CD8+ cytotoxic T-cells and CD4+ T-cells to produce IFN-γ, which in 
turn possibly leads to insulin resistance (D. A. Winer et al., 2011). Like T-cells, B-cells 
also have an alternative regulatory phenotype, called regulatory B-cells (Bregs). A study 
by Nishimura et al. (2013) found that a unique subpopulation of Bregs specifically 
residing in lean adipose tissue is one of the main sources of the anti-inflammatory 
cytokine IL-10 expressed in adipose tissue (Nishimura et al., 2013). The same study 
demonstrated that knocking out the B-cell specific IL-10 gene increased numbers of 
CD8+ cytotoxic T-cells and pro-inflammatory macrophages and decreased insulin 
sensitivity in obese adipose tissue (Nishimura et al., 2013). A study by Wang et al. (2014) 
showed that one mechanism of inducing this Breg phenotype is through interleukin-35 
(IL-35) signaling (R.-X. Wang et al., 2014). 
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In summary, multiple studies demonstrate that obesity induces inflammation 
response in adipose tissue, and that this leads to insulin resistance and other metabolic 
pathologies. Inflammation in obese adipose tissue is characterized by higher levels of 
Th1 CD4+ cells, pathogenic IgG-producing B-cells, pro-inflammatory macrophages 
accompanied by the decrease in Th2 CD4+ cells, CD4+ Foxp3+ Tregs, and Bregs. Pro-
inflammatory mediators that have been causally implicated in insulin resistance include 
the inflammasome and TNF. On the other hand, the anti-inflammatory cytokine IL-10 
directly antagonizes the detrimental effects of TNF on insulin signaling, leading to better 
glucose tolerance (Lumeng et al., 2007). In addition, the results from these studies show 
that the innate and adaptive immune response affect each other, leading to an overall pro-
inflammatory or anti-inflammatory environment in adipose tissue. For example, 
eosinophils secrete IL-4 which causes T-cells to differentiate into Th2 CD4+ cells and 
secrete further anti-inflammatory cytokines. Meanwhile, Th1 CD4+ cells secrete IFN-γ, a 
pro-inflammatory cytokine that causes macrophages to produce more pro-inflammatory 
mediators. 
 
Neuroinflammatory response following stroke 
 
In addition to responding to infections and invading pathological microorganisms 
in the human body, the innate immune system also responds when tissue is damaged in 
stroke. One group of receptors that play a part in activating this innate immune response 
is the toll-like receptors (TLRs) (Abbas et al., 2016d). Microglia, the resident 
macrophages of the central nervous system (CNS), are known to possess TLRs 1-9 
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(Olson & Miller, 2004), which can each respond to different ligands and DAMPs, 
including those released from damaged blood vessels, extracellular matrix (ECM), and 
necrotic cells (Karikó, Weissman, & Welsh, 2004). For example, mRNA released from 
necrotic cells can bind to and activate TLR 3 (Karikó, Ni, Capodici, Lamphier, & 
Weissman, 2004) while fibronectin, a component found in the ECM binds and activate 
TLR 4 (Okamura et al., 2001). Other DAMPs released during cell death include high 
mobility group box-1, heat shock proteins, and low-density lipoprotein (Famakin, 2014). 
TLR activation leads to signaling cascades that activate transcription factors such as NF-
κB and interferon regulator factors (IRFs), which cause increased expression of pro-
inflammatory cytokines and adhesion molecules (Abbas et al., 2016d). Inflammasomes 
such as NLRP3 are also involved in innate immunity by upregulating pro-inflammatory 
cytokines and respond to tissue death through sensing substances that indicate cellular 
death such as extracellular adenosine triphosphate (ATP) and uric acid crystals derived 
from nucleic acids (Abbas et al., 2016d).  
As mentioned above, microglia are the resident macrophages of the CNS. They 
have a variety of functions in the normal brain including synaptic remodeling, clearing 
debris, and constantly surveying their environment through dynamic movements of their 
ramified processes (Nimmerjahn, Kirchhoff, & Helmchen, 2005; Patel, Ritzel, 
McCullough, & Liu, 2013). Microglia response to CNS damage caused by stroke in the 
acute phase of neuroinflammation, which is loosely defined as the relatively immediate 
time period after the occurrence of stroke. In fact, they become activated as early as 2 
hours after the onset of ischemic stroke (Kawabori & Yenari, 2015). As mentioned 
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earlier, one possible mechanism of microglia activation is through the DAMP pathway, 
where DAMPs released by necrotic cells can bind to TLRs on microglia and initiate 
cellular changes (Patel et al., 2013). Microglia in the injured brain are also able to sense 
extracellular ATP released from damaged cells. In response, they extend and move their 
processes towards the injured site and form a barrier between damaged and normal tissue 
(Davalos et al., 2005). In addition, microglia are shown to actively undergo cellular 
division after an ischemic stroke, leading to increased numbers of microglia in the areas 
surrounding the infarct core (T. Li et al., 2013). Overall, the activation, proliferation, and 
overall “intense reaction” of microglia is called “microgliosis” (T. Li & Zhang, 2016). 
Like peripheral macrophages, microglia can adopt a more pro-inflammatory or 
anti-inflammatory phenotype. Microglia are known to release anti-inflammatory 
cytokines such as IL-10, IL-4, and transforming growth factor-β (TGF-β), which helps 
with tissue repair and neuroprotection (Patel et al., 2013). In contrast, microglia can also 
release pro-inflammatory cytokines like TNF, IL-1β, IFN-γ, and IL-6 as well as other 
pro-inflammatory molecules like matrix metallopeptidases (MMPs), reactive oxygen 
species (ROS) and nitric oxide synthase (NOS), which further exacerbates the 
neuroinflammatory response (Patel et al., 2013). A study by Gregersen et al. (2000) 
shows that microglia and infiltrating monocyte-derived macrophages (MDMs) are 
responsible for the elevated levels of TNF seen early after stroke, which peak at 12 hours 
after middle cerebral artery occlusion (MCAO), a common ischemic stroke model used in 
animals (Gregersen, Lambertsen, & Finsen, 2000). One study by Hu et al. (2012) found 
that microglia and infiltrating macrophages secrete anti-inflammatory cytokines like 
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TGF-β and IL-10 at 1 to 3 days after MCAO, and that microglia and infiltrating 
macrophages start expressing pro-inflammatory mediators such as iNOS from day 3 and 
onwards (Hu et al., 2012). Other studies in different CNS injury models have also 
supported a transition from a more anti-inflammatory to a more pro-inflammatory 
phenotype in microglia and peripheral macrophages (Hu et al., 2015).  
Astrocytes, another type of glial cell, also undergo functional and physical 
changes during the acute phase of neuroinflammation. Astrocytes are normally 
responsible for a number of roles in the CNS, including guiding neuronal development, 
regulating neurotransmitter metabolism, maintaining synapses, and maintaining the blood 
brain barrier (BBB) (Dong & Benveniste, 2001). The BBB is a tightly regulated barrier 
that helps prevent changes in plasma composition from affecting brain function (Abbott, 
2002). Like microglia, astrocytes also undergo a number of changes in response to brain 
ischemic injury, such as increased swelling (Garcia, Kalimo, Kamijyo, & Trump, 1977), 
increased calcium ion signaling, and upregulation of glial fibrillary acidic protein 
(GFAP), an intermediate filaments protein expressed by astrocytes (Choudhury & Ding, 
2016). In addition to the change from a normal astrocyte phenotype to a reactive 
astrocyte phenotype during brain ischemic injury, there is proliferation of astrocytes 
(Panickar & Norenberg, 2005) and later on, the formation of a glial scar in the penumbra 
around the stroke core, separating healthy tissue from damaged tissue (Choudhury & 
Ding, 2016). It is known that this glial scar formed by astrocytes undergoes remodeling 
and persists during the chronic phase and beyond after stroke (Burda & Sofroniew, 
 
 
 
 
13 
 
 
2014). These phenotypical changes and reactions by astrocytes to brain injury are termed 
“astrogliosis”. 
Astrocytes also play a prominent role in the acute immune response after stroke. 
Like microglia, astrocytes also express TLRs (Farina, Aloisi, & Meinl, 2007), and can 
respond to DAMPs and other ligands released from damaged tissue after stroke. 
Astrocytes can interact with and activate microglia and other infiltrating cells in the CNS 
after ischemic stroke. For example, astrocytes can release ATP which in turn activates 
microglia (Takano, Oberheim, Cotrina, & Nedergaard, 2009). A study by Inose et al. 
(2015) also found that astrocytes can release the molecule lysophosphatidylcholine, 
which induces expression of the pro-inflammatory mediators MCP-1 and its receptor C-C 
chemokine receptor type 2 (CCR-2) in microglia after ischemic stroke (Inose, Kato, 
Kitagawa, Uchiyama, & Shibata, 2015). Furthermore, another study by Che et al. (2001) 
suggests that astrocytes themselves also produce and release MCP-1 (Che, Ye, Panga, 
Wu, & Yang, 2001). Astrocytes are also known to be APCs and therefore express MHC-
II, meaning they are capable of activating T-cells in the CNS (Dong & Benveniste, 2001), 
therefore playing a role in priming the adaptive immune response. Together, these studies 
show that astrocytes play a role in both innate and adaptive immunity in the CNS.  
Different studies suggest that astrocytes play a neuroprotective role after stroke. A 
study by Nawashiro et al. (2000) shows that mice lacking glial fibrillary acid protein 
(GFAP), which is upregulated by astrocytes during astrogliosis, have larger infarcts and 
decreased cortical cerebral blood flow after MCAO and tMCAO compared to those found 
in wild type mice (Nawashiro, Brenner, Fukui, Shima, & Hallenbeck, 2000). This 
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suggests that GFAP in astrocytes helps attenuate the progress of further brain damaged 
initiated by ischemic stroke (Nawashiro et al., 2000). Another study done by Hayakawa 
et al. (2010) suggested that astrocytes also contribute to neurovascular remodeling and 
improves motor functioning after ischemic stroke in mice (Hayakawa et al., 2010). By 
inhibiting the metabolism in astrocytes 5 days after onset of ischemic stroke, mice have 
worst neurovascular remodeling and motor functioning compared to those with 
uninhibited astrogliosis (Hayakawa et al., 2010). 
 While the studies mentioned above showcase the beneficial effects of astrocytes, 
there are other studies that demonstrate that they can have detrimental effects. A study by 
Wang et al. (2008) demonstrated that astrogliosis after MCAO in rats is closely 
associated with neuronal death and that inhibiting astrocyte proliferation that occurs 
during astrogliosis after MCAO decreases this neuronal death (W. Wang et al., 2008). In 
addition, a study by Dvoriantchikova et al. (2009) suggests that inhibiting NF-κB 
signaling in astrocytes after ischemic injury decreases the levels of pro-inflammatory 
mediators such as ICAM-1, VCAM-1, MCP-1, TNF, and NOS and increases the survival 
of neurons within the injured region (Dvoriantchikova et al., 2009). A recent study by 
Liddelow et al. (2017) even found that microglia are able to induce a subpopulation of 
reactive astrocytes called “A1 astrocytes”, which then induces the death of neurons and 
oligodendrocytes (Liddelow et al., 2017).  
As mentioned earlier, both microglia and astrocytes secrete pro-inflammatory 
cytokines and chemokines, which recruit other innate immune cells into infarct area 
(Benveniste, 1997; J. Y. Kim, Park, Chang, Kim, & Lee, 2016). Chemokines such as 
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MCP-1 and cytokine-induced neutrophil chemoattractant (CINC) help recruit monocytes 
and neutrophils to the site of injury, respectively (Huang, Upadhyay, & Tamargo, 2006). 
Pro-inflammatory cytokines such as TNF and interleukin-1 (IL-1) induce endothelial 
cells of the cerebral microvasculature to upregulate adhesion molecules including E-
selectins, P-selectins, intercellular adhesion molecule-1 (ICAM-1), and vascular cell 
adhesion molecule-1 (VCAM-1), which allow innate immune cells such as neutrophils 
and monocytes from the systemic circulation to bind to the endothelium of these blood 
vessels and infiltrate into the injured brain tissue (Abbas et al., 2016d; Stanimirovic, 
Wong, Shapiro, & Durkin, 1997; R. Zhang, Chopp, Zhang, Jiang, & Powers, 1998). 
In addition to homeostatic regulation of the environment in the brain (Abbott, 
2002), the BBB is also important for restricting peripheral immune cells from entering 
the CNS (Muldoon et al., 2013). However, the BBB increases in permeability early after 
stroke, contributing to neuroinflammation. An early study by Rosenberg et al. (1998) 
found that the BBB increased its permeability at two time points, at 3 hours and 48 hours 
after a transient middle cerebral artery occlusion (tMCAO), an animal model of ischemic 
stroke where the MCA is only temporarily occluded (Rosenberg, Estrada, & Dencoff, 
1998; Turner & Sharp, 2016). The permeability of the BBB then later went back to 
normal levels by 14 days after tMCAO (Rosenberg et al., 1998; Turner & Sharp, 2016). 
The increased BBB permeability seen at 3 hours after tMCAO is associated with 
increased levels of MMP-2 (matrix metallopeptidase-2) and the increased permeability 
seen after 48 hours was associated with increased levels of MMP- 9 (matrix 
metallopeptidase-9) (Rosenberg et al., 1998; Turner & Sharp, 2016). Both of these 
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enzymes contribute to the breakdown of extracellular matrix components of the cerebral 
vasculature and it is shown that neutrophils may be a major contributor to the increased 
levels of MMP-9 after stroke (Huang et al., 2006; Justicia et al., 2003; Turner & Sharp, 
2016). This opening of the BBB soon after stroke is associated with increased infiltration 
of peripheral immune cells into the injured brain (Turner & Sharp, 2016). In addition, the 
increased BBB permeability is also associated with edema in the same hemisphere where 
the stroke occurred (Bralet, Beley, Beley, & Bralet, 1979).  
 Although the timing of the infiltration of systemic immune cells into the brain 
may vary between different stroke models, species, and studies, the first responders of 
ischemic stroke from the peripheral circulation generally include monocytes and 
neutrophils, both of which are part of the innate immune system (Chu et al., 2014; 
Famakin, 2014; Gelderblom et al., 2009; Grønberg, Johansen, Kristiansen, & Hasseldam, 
2013; Hallenbeck et al., 1986; Schroeter, Jander, Witte, & Stoll, 1994).  
Neutrophils, a type of granulocyte, develop in the bone marrow and can respond 
to damaged tissue by infiltrating into the site of injury and phagocytosing necrotic tissue, 
although their life span is only a few hours once in the extravascular tissue (Abbas et al., 
2016d). Studies show that neutrophils start infiltrating into the injured hemisphere of the 
brain as early as 1 to 3 hours after stroke, with peak levels of infiltration at 1 to 3 days 
after stroke, although these studies have variations between the time of onset of 
infiltration, based on the stroke model (Famakin, 2014; Grønberg et al., 2013; Hallenbeck 
et al., 1986). To reach to the site of injury, neutrophils exocytose granules containing 
proteases including elastases, collagenases, and gelatinases (such as MMP-9), which 
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facilitate the breakdown components of the ECM (Turner & Sharp, 2016). It is thought 
that the BBB breakdown and release of proteases and ROS by neutrophils can possibly 
contribute to more tissue damage, but neutrophils may also contribute to beneficial 
effects such as vascular remodeling and angiogenesis after stroke (Jickling et al., 2015). 
 Like neutrophils, monocytes are made in the bone marrow and recruited early on 
after stroke (Abbas et al., 2016d). Once monocytes are recruited into the target tissue, 
they can then differentiate into macrophages, which tend to survive longer in the brain 
than neutrophils (Abbas et al., 2016d). MDMs are observed in the injured hemisphere as 
early as 12 hours after stroke and have a peak response at days 3 and 7 after stroke 
(Gelderblom et al., 2009; Grønberg et al., 2013). Since microglia are CNS-specific 
macrophages that populate the CNS during embryonic development (Abbas et al., 
2016d), they have many similar phenotypes to peripheral macrophages, which makes 
them difficult to distinguish from each other (Patel et al., 2013). For example, the cell 
marker CD68 is found on both microglia and peripheral macrophages. As such, the extent 
to which infiltrating macrophages contribute to microgliosis is still being debated (Greter, 
Lelios, & Croxford, 2015; T. Li et al., 2013). Like microglia, infiltrating macrophages 
likely polarize into pro-inflammatory or anti-inflammatory phenotypes, allowing them to 
phagocytose necrotic tissue and perpetuate neuroinflammation or become involved with 
tissue repair (Abbas et al., 2016d). 
Although peripheral macrophages are thought to be the earlier responders after 
stroke, there are studies showing that they can infiltrate into the infarct core after the 
acute phase. By labeling peripheral macrophages with fluorine-19, Vindegaard et al. 
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(2017) demonstrated that the number of infiltrating peripheral macrophages actually 
peaks at 14 days in the infarct area after MCAO, and that there continue to be high 
numbers in this area even at 28 days after MCAO (Vindegaard et al., 2017). Another 
study performed by Doyle et al. (2015) showed increased numbers of peripheral 
macrophages and/or microglia in the infarct core of mice at 7 weeks after middle cerebral 
artery occlusion with hypoxia (DH) stroke, an ischemic stroke model where the distal 
portion of the MCA is occluded and the animal is further subjected to hypoxia, and that 
these cells possibly contribute to a larger adaptive immune response that worsens stroke 
outcomes (Doyle et al., 2015). It is important note that the increased CD68 expression in 
the stroke core in this study by Doyle et al. (2015) may also represent the proliferation of 
microglia or their migration from other parts of the brain, in addition to increased 
infiltration or proliferation of peripheral macrophages.   
Many studies show that the pro-inflammatory mediators released by microglia 
and peripheral macrophages contribute to larger brain damage after stroke. In a study by 
Giulian et al. (1993), the immunosuppression of both microglia and macrophages with 
chloroquine and colchicine, which are both known to be macrophage suppressors, 1 hour 
after tMCAO in rats resulted in lower amounts of neurotoxic compounds, possibly 
leading to higher rates of neuron survival (Giulian, Corpuz, Chapman, Mansouri, & 
Robertson, 1993). Another study by Chen et al. (2009) showed that inhibiting 
Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase in mice, which is 
expressed in microglia and is a responsible for producing ROS, resulted in a 50% 
decrease in the infarct area after MCAO compared to the infarct areas in mice without 
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NADPH oxidase inhibition (Chen, Song, & Chan, 2009). Microglia are also a source for 
MMPs (Kawabori & Yenari, 2015) and a study by Asahi et al. (2000) showed that 
knocking out the MMP-9 gene or inhibiting its enzymatic activity in mice after ischemic 
injury reduces the lesion size (Asahi et al., 2000). These studies show the detrimental 
effects microglia and macrophages can exert on neural tissue after ischemic stroke.   
However, there is also evidence that macrophages can be neuroprotective in 
ischemia. A study by Neumann et al. (2006) showed that the application of microglia to 
rat hippocampal sections at 24 hours before oxygen-glucose deprivation (OGD), another 
model of ischemic injury, protected neurons from OGD-induced damage (Neumann et 
al., 2006). This study further showed that microglia with downregulated CD11a, which is 
involved in cellular adhesion, fails to provide protection against OGD-induced damage, 
suggesting that adhesion of microglia to neurons after OGD is a mechanism involved in 
neuroprotection (Neumann et al., 2006). Another study by Imai et al. (2007) found that 
intravenous injection of cultured microglia as late as 24 hours after global forebrain 
ischemia in gerbils resulted in decreased damage to neurons (Imai et al., 2007). 
Furthermore, microglia-treated animals had normal memory performance and increased 
neurotrophic factors like brain-derived neurotrophic factors and glia cell-derived 
neurotrophic factor, which contributes to the survival of neurons (Imai et al., 2007). 
 There is evidence that T-cells are involved in the immunological pathology of 
ischemic stroke, although their involvement is not as well studied as those of other 
leukocytes (Arumugam, Granger, & Mattson, 2005). An early study done by Jander et al. 
(1995) shows that T-cells can adhere to cortical vasculature between 1 to 2 days after 
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ischemic stroke in rats and that there are increased numbers of T-cells by 3 days in the 
area surrounding the infarct core (Jander, Kraemer, Schroeter, Witte, & Stoll, 1995). A 
study by Stevens et al. (2002) using flow cytometry also verifies this increased T-cell 
levels at 3 days after ischemic stroke (Stevens et al., 2002). 
T-cells are involved in the chronic phase after ischemic stroke, which is loosely 
defined as weeks after the onset of stroke. From labeling peripheral lymphocytes, Feng et 
al. (2017) found that lymphocyte infiltration is seen even 14 days after ischemic stroke 
models in mice, including CD4+ T-cells, CD8+ T-cells, as well as natural killer T-cells 
(Feng et al., 2017). This time point after stroke corresponds with increased expression of 
ROS and inflammatory cytokines like IFN-γ and TNF (Feng et al., 2017). Vindegaard et 
al. (2017) even demonstrated a significant increase in T-cell numbers 28 days after 
MCAO in mice (Vindegaard et al., 2017). Studies suggest that T-cells exacerbate the 
neuroinflammation response after ischemic stroke and leads to worse stroke outcomes. A 
study by Kleinschnitz et al. (2010) showed that mice lacking mature T and B cells have 
reduced infarct volumes after tMCAO compared to wild type mice, but administering T-
cells into mature T and B-cell null mice results in infarct sizes and motor functional 
deficits similar to those found in wild type (Kleinschnitz et al., 2010). 
On the other hand, it is also demonstrated that different subtypes of T-cells play 
different roles after stroke As described above, the CD4+ T-cell population can be further 
divided into different cell subpopulation, including Th1, Th2, and Th17 cells, based on 
the cytokines it produces and its ability to activate different cell types (Abbas et al., 
2016b). Th1 CD4+ cells are able to release IFN-γ and able to polarize macrophages into 
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the M1 phenotype (Abbas et al., 2016b). They can also activate microglia, increase 
vascular permeability, and increase major histocompatibility complex I expression, 
further exacerbating the inflammatory response (Arumugam et al., 2005). Th17 CD4+ 
cells are known to contribute to the inflammatory response by producing pro-
inflammatory cytokines such as interleukin-22 (IL-22) (Stockinger, Veldhoen, & Martin, 
2007). On the other hand, Th2 CD4+ cells are able to secrete anti-inflammatory cytokines 
including IL-4, IL-10, and IL-13 (Abbas et al., 2016b). Note that these different T-cell 
subtypes are also involved in a variety of pathophysiological states besides stroke, as seen 
earlier in chronic obesity. 
It is thought that these different subpopulations of CD4+ T-cells may each play a 
unique role in promoting or inhibiting the neuroinflammatory response after ischemic 
stroke. The study by Gu et al. (2012), one of the few studies that looked at the 
neuroinflammatory roles of different CD4+ T-cell subtypes after stroke, found that Th2 
CD4+ T-cell- deficient mice have larger infarct sizes and worst neurological deficits 
while mice deficient in Th1 CD4+ T-cells have smaller infarct sizes and less neurological 
deficits compared to wild type mice after ischemic stroke (Gu et al., 2012). This study 
also found an increase in neutrophil and macrophage activity 2 days after stroke in Th2 
CD4+ T-cell deficient mice while the activities of these cells decreased in Th1 CD4+ T-
cell deficient mice (Gu et al., 2012). Furthermore, they also found in vitro that Th1 CD4+ 
T-cell deficiency leads to lesser neuronal death, while Th2 CD4+ T-cell deficiency 
causes more neuronal death (Gu et al., 2012). These results are expected, since Th1 
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CD4+ T-cells are shown to be pro-inflammatory while Th2 CD4+ T-cells have anti-
inflammatory properties. 
There are also studies that attempt to understand the different possible mechanism 
that T-cells may use to worsen neuroinflammation after stroke. A recent study by Zhao et 
al. (2018) suggests that first apoptosis signal receptor ligand (FasL) on CD4+ cells 
promote microglia to adopt an pro-inflammatory phenotype via the NF-κB pathway after 
ischemic stroke (Zhao et al., 2018). Brait et al. (2010) showed that T-cells can contain 
NADPH oxidase 2, which contributes to the increased levels of superoxides after 
ischemic stroke in male mice models, suggesting another mechanism that T-cells may use 
to contribute to neural injury (Brait et al., 2010). 
Like T-cells, B-cells are also thought to be the late responders in the 
neuroinflammatory response after stroke. While T-cells also respond during the acute 
phase after stroke, there is a disagreement in the literature as to whether B-cells are 
involved in the acute phase. Several studies found that B-cells most likely do not play a 
major role during the acute phase. Schumann et al. (2017) reported that B-cell deficient 
mice had similar infarct sizes to those in control mice at day 1 and 3 after tMCAO 
(Schuhmann, Langhauser, Kraft, & Kleinschnitz, 2017). In this study, B-cell deficient 
mice had similar numbers of monocytes and neutrophils in the ipsilateral hemisphere 
compared to control mice (Schuhmann et al., 2017). Additionally, there was also no 
difference in the amount of neuronal apoptosis, the degree of astrogliosis, or the levels of 
TNF and IL-1β between these two groups (Schuhmann et al., 2017). A study by 
Kleinschnitz et al. (2010) found that reconstituting B-cells in T and B-cell deficient mice 
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does not significantly change the infarct size compared to that of T and B-cell deficient 
mice 24 hours after tMCAO, further suggesting that B-cells do not contribute to the 
damage found at this time point (Kleinschnitz et al., 2010).  
In contrast with these studies, Ren et al. (2011) demonstrated that B-cell deficient 
mice had larger infarct sizes and more severe sensorimotor deficits at 48 hours after 60 
min. of tMCAO, accompanied with increased numbers of neutrophils, T-cells, and 
macrophages in the ipsilateral hemisphere (Ren et al., 2011). It was further found that 
restoring B-cells in B-cell deficit mice eliminated these affects from tMCAO, but 
transferring IL-10 deficient B-cells into B-cell deficient mice did not reduce infarct size 
or improve neurological functioning (Ren et al., 2011). Overall, this study suggests that 
B-cells exert neuroprotective effects early after stroke by producing IL-10. 
Doyle et al. (2015) reported that B-cells are rarely found in coronal sections of 
mice brain 1 week after DH stroke (Doyle et al., 2015). However, B-cells are observed in 
the stroke core in the chronic phase at 7 weeks after DH stroke and even at 12 weeks after 
DH stroke (Doyle et al., 2015). In addition, these B-cells are in close proximity to 
dendritic cells and T-cells, and 9% of the B-cells in the stroke core at 7 weeks after 
dMCAO matured into antibody-synthesizing plasma cells (Doyle et al., 2015). This is not 
surprising, as dendritic cells and CD4+ T-cells are crucial for presenting antigens to B-
cells for activation and for providing proliferation and isotype switching signals (Abbas, 
Lichtman, & Pillai, 2016c; Wykes & Macpherson, 2000). Furthermore, the large number 
of B-cells in the stroke core at 7 weeks after DH stroke in mice corresponds with an onset 
of cognitive deficits, which is measured by two tasks that both assess cognition (Doyle et 
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al., 2015). At this time point, these mice also developed a deficit in long-term 
potentiation (LTP) in the hippocampus, which is an electrophysiological correlate of 
memory (Doyle et al., 2015). 
Interestingly, Doyle et al. (2015), also reported that the levels of IgG1, IgG2, and 
IgA antibodies were elevated in adjacent brain regions 7 weeks after stroke compared to 
sham animals, and that there is a significant increase in IgA levels between week 1 and 7 
after stroke, suggesting that B-cells had undergone both IgG and IgA isotype switching 
between week 1 and 7 after stroke (Doyle et al., 2015). The authors speculated that the 
antibodies produced by these B-lymphocytes might activate Fc receptors, mediate 
complement protein activation, or target host tissue in an autoreactive fashion, 
contributing to the neurological dysfunction observed at 7-weeks after stroke (Doyle et 
al., 2015). To further confirm that this delayed-cognitive deficit is due to B-cells found in 
the stroke core, B-cells were ablated 5 days after dMCAO (Doyle et al., 2015). This 
prevented the delayed-cognitive deficits at 7 weeks after dMCAO (Doyle et al., 2015).  
 
Neuroinflammation in obesity and stroke outcomes 
 As previously mentioned, the inflammatory response is intimately involved in the 
progression of brain tissue damage in stroke, stroke outcomes, and obesity-related 
pathologies, which makes the link between obesity and stroke even stronger. Many 
studies have looked at the outcome of stroke in animal and human studies, while many 
others have attempted to understand the mechanisms mediating the relationship between 
obesity and stroke. There are different animal models used to study obesity, with some of 
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the most common ones being leptin-deficient (ob/ob) rodents, leptin receptor-deficient 
(db/db) rodents, or HFD-fed rodents (Haley & Lawrence, 2016).  
 In most animal studies, obesity generally leads to worse brain damage and 
behavioral outcomes after stroke (Haley & Lawrence, 2016). Studies that use HFD-fed 
rodents and ob/ob rodents found that obese animals tend to have larger infarcts after 
experimental ischemic stroke compared to normal diet animals or genetically normal 
animals (Cao, Du, Zhang, Yan, & Hu, 2015; Haley et al., 2017; E. Kim, Tolhurst, & Cho, 
2014; Maysami et al., 2015; Terao et al., 2008). 
Studies have also suggested that the duration of HFD and the duration of 
occlusion of blood flow in ischemic stroke models can impact the severity of tissue 
damage in the brain. For example, a study by Maysami et al. (2015) found that mice on 
either 2 or 3 months of HFD that underwent 30 minutes of tMCAO and 24 hours of 
reperfusion have no difference in infarct size compared to those mice on a normal diet, 
but mice that underwent 4 months of HFD and 30 minutes of tMCAO and 24 hours of 
reperfusion have a significantly larger infarct size compared those on normal diet 
(Maysami et al., 2015). In addition to length of consumption of HFD, longer periods of 
arterial occlusion during tMCAO increases the infarct size in HFD animals (Maysami et 
al., 2015). Mice on 6 months of HFD that underwent 20 minutes of tMCAO and 24 hours 
of reperfusion have no difference in infarct size compared to those in normal animals, but 
animals on 6 months HFD that underwent 30 minutes of tMCAO and 24 hours of 
reperfusion have a significantly larger infarct size compared to those normal animals 
(Maysami et al., 2015). However, not all studies agree that only longer periods of HFD 
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causes increased infarct areas. For example, a study done by Haley et al. (2017) found 
that 24 hours after tMCAO in mice on 3 days of HFD there was a 48% increase in infarct 
volume, although there is no difference in inflammatory markers in the periphery or brain 
(Haley et al., 2017). This suggests that even acute HFD consumption may cause 
significant increases in infarct size. 
 Many studies have found increased levels of pro-inflammatory chemokines and 
cytokines after ischemic stroke in obese animals compared to those levels in normal diet 
mice. These studies found that increased TNF, IL-6, chemokine C-C motif ligand-3 
(CCL-3), chemokine C-X-C motif ligand (CXCL) and MCP-1 in obese animals, which 
exacerbates the neuroinflammatory response after ischemic stroke (Cao et al., 2015; 
Maysami et al., 2015; Terao et al., 2008). Maysami et al. (2015)  showed an increase in 
neutrophil, microglia, and macrophage counts in the striatum 24 hours after 30 minutes of 
tMCAO in animals on 6 months of HFD compared those counts found in normal diet 
animals (Maysami et al., 2015). In addition, Teraro et al. (2008) found that leptin-
deficient mice have increased white blood cell and platelet adhesion onto cerebral 
venules 4 hours after tMCAO compared to genetically normal mice (Terao et al., 2008) 
while another study by Cao et al. (2015) showed an upregulation of adhesion molecules 
VCAM-1 and ICAM-1 in the brain, which help leukocytes infiltrate into the injured 
neural tissue (Cao et al., 2015). Both these studies demonstrate an increased recruitment 
of immune cells to the brain in obese animals after ischemic stroke.   
The BBB opening that occurs after stroke is also exacerbated in obese animals. 
Maysami et al. (2015) found a larger disruption of the BBB in the cortex at 24 hours after 
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30 min tMCAO in animals on 6 months of HFD compared to those on normal diet 
(Maysami et al., 2015). Teraro et al. (2008) also showed an increased opening on the 
BBB in leptin-deficient mice at 24 hours after tMCAO compared to that found in wild 
type mice (Terao et al., 2008). Studies suggest that increased disruption of the BBB is 
associated with increased level of MMPs in obese animals after ischemic injury. Db/db 
mice exhibit an increased degradation of occludin and collagen IV by MMP-9, which are 
components of the BBB, causing these mice to have increased BBB permeability after 
ischemic injury (Kumari, Willing, Patel, Baskerville, & Simpson, 2011). Another study 
by Deng et al. (2014) also showed increased BBB damage as well as increased 
hemorrhagic transformation in HFD animals after tMCAO (Deng, Zhang, Feng, Xiong, 
& Zuo, 2014). MMP-9 deficient mice on HFD have smaller hemorrhagic volumes in the 
brain after tMCAO compared to those found in genetically regular mice on HFD, and 
when placed on HFD they do not have worse functional motor outcomes compared to 
MMP-9 deficient mice on normal diet (Deng et al., 2014). These results indicate that 
MMP-9 is crucial contributor to the worsened stroke outcomes in obese animals. 
Motor function after ischemic stroke tends to be worse in studies on obese 
animals (Deng et al., 2014; Dhungana et al., 2013). In a recent study done in our 
laboratory, motor functioning performance was examined at 1, 3, 7, 14 and 28 days after 
photothrombotic stroke in mice on HFD or normal diet. The photothrombotic stroke 
model was utilized in this study because of its ability to induce a thrombus at a specific 
area in the cortex. Since we were specifically studying motor functioning after stroke, we 
placed the stroke in the motor cortex. Consistent with the spontaneous motor recovery 
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found in the literature, animals in both diet group performed better in the motor function 
tasks during each successive time point. However, the animals on HFD have worse 
performance at all these time points compared to animals on normal diet. 
 Besides impaired motor functioning, obese human patients tend to have larger 
cognitive deficits after ischemic stroke compared to patients of normal weight (P. Li et 
al., 2016; Lu, Ren, Zhang, & Sun, 2016; Yong Zhang et al., 2012). In fact, it has even 
shown that normal weight human participants tend to perform better on certain cognitive 
tasks even after controlling for obesity-related diseases, such as stroke and diabetes 
(Nilsson & Nilsson, 2009). Currently, a few animal studies have looked at the association 
between post-stroke dementia and obese/diabetic rat models. Indeed, these studies 
indicate that obese/diabetic rats have increased cognitive deficits after ischemic stroke 
compared to normal rats that also underwent ischemic stroke, and these studies attributed 
this cognitive deficit to abnormal phosphorylation of tau proteins and beta-amyloid 
generation in the hippocampus (T. Zhang et al., 2009; Ting Zhang, Pan, Sun, Sun, & Sun, 
2010). No animal studies have looked directly at obesity-induced neuroinflammation and 
its effects on delayed-onset cognitive deficits after stroke. 
One interesting phenomenon worthy of mention is the obesity paradox in the 
context of stroke outcomes. While most preclinical/animal studies demonstrate that 
obesity is associated with impaired stroke recovery, there are some clinical studies 
showing that patients with higher BMIs actually had improved functional recovery, lower 
rates of short-term mortality, and lower rates of reoccurring strokes (Haley & Lawrence, 
2016). It is unclear whether these studies actually reflect a true biological phenomenon, 
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or if this phenomenon is due to the differences in methodology and sampling in these 
studies (Haley & Lawrence, 2016). 
 
Summary and current study 
 Both obesity and ischemic stroke stimulate an immune response. Metabolic 
malfunctions such as insulin insensitivity observed in obesity are largely attributed to the 
chronic pro-inflammatory baseline which is characterized by the upregulation of pro-
inflammatory mediators and immune cells like Th1 CD4+ cells, CD8+ cytotoxic cells, B-
cells, and macrophages. On the other hand, the immune response after ischemic stroke in 
different studies are shown to be both beneficial and detrimental. The neuroinflammatory 
response at different time periods after ischemic stroke may have differential effects on 
stroke outcomes, but this is not well understood. It is also important to note that studies 
use many different models of experimental stroke, leading to the possibility that the 
neuroinflammatory phenotype and stroke outcomes may also depend on the stroke model 
used. 
 As mentioned earlier, most animal studies find that obesity exacerbates the 
neuroinflammatory response after stroke, leading to worse functional recovery. To further 
support this notion, our laboratory has shown that mice on HFD have significantly 
increased infarct size 72 hours after dMCAO compared to that normal diet animals 72 
hours after dMCAO. This study also shows that HFD animals have higher levels of 
astrogliosis and microgliosis in the peri-infarct region 72 hours post-dMCAO, suggesting 
that the neuroinflammatory response may be contributing to the increased infarct size at 
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this time point. As previously indicated, it is found that HFD animals have worse motor 
recovery compared to normal diet animals after stroke. We additionally found that HFD 
animals have larger increases in pro-inflammatory mediators including NF-κB, NLRP3, 
MCP-1 and TNF 72 hours post-dMCAO. This supports previous literature that described 
upregulation of inflammatory pathways in the acute phase after stroke, including the 
inflammasome, in obese animal models. 
 While many studies, including our previous study, have characterized the 
neuroinflammatory response in obesity and its effects on stroke outcomes in the acute 
phase after ischemic, very few studies have considered this response in obese animal 
models during the chronic phase and its impact on functional recovery. In fact, no studies 
have looked directly at the effects of obesity-induced neuroinflammation on ischemic 
brain damage and cognitive functioning during the chronic phase.  
Therefore, we were interested in characterizing the neuroinflammatory response 
and ischemic tissue damage in the chronic phase after stroke in obese animals. 
Furthermore, we would like to study whether these have an association with performance 
in cognition tasks. The study by Doyle et al. (2015) showed that mice have an increased 
adaptive immune response in the infarct core 7 weeks after stroke and that this likely 
contributes to the development of the cognitive deficits seen 7 weeks after stroke (Doyle 
et al., 2015). Based on the works of Doyle et al. (2015), our finding of a larger 
neuroinflammatory response and increased infarct expansion in obese animals, and the 
evidence of worse stroke outcomes in obese animals, we hypothesized that obese animals 
would have worse cognitive outcomes in the chronic phase after stroke compared to 
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normal diet animals. We also predicted that the neuroinflammatory response, e.g. 
astrogliosis, microgliosis, and increased T and B-cell infiltration, would be elevated in 
these obese animals during the chronic phase after stroke and contribute to increased 
brain tissue damage and ultimately delayed-cognitive deficits. 
 
METHODS 
 
Animal usage 
All use of animals was conducted according to protocols approved by the 
Stanford Institutional Animal Care and Use Committee and the NIH Guide for Care and 
Use of Animals. Forty 3-4-month-old female C57BL/6J mice (#664, The Jackson 
Laboratories, Bar Harbor, ME), were used in total for this study. Animals were given free 
access to food and water and kept on a 12-hour light/dark cycle. Each cage housed five 
mice. 
 
High-fat diet and regular diet 
All HFD-fed animals were fed a HFD chow of 60% kCal fat (#D12492, Research 
Diets Inc., New Brunswick, NJ) for 6 weeks before surgery, while all the normal diet 
animals were fed a regular diet of 6% kCal fat (#2018SX, Harlan Laboratories, 
Indianapolis, IN) also for 6 weeks before surgery (Figure 1). After surgery, animals 
previously on HFD remained on HFD afterwards. Animals that received normal diet for 6 
weeks remained on the normal diet afterwards.  
 
 
 
 
32 
 
 
 
Stroke surgery 
All mice used in our experiments underwent either a dMCAO to mimic an 
ischemic stroke or a sham surgery. For all surgeries, animals were placed in a chamber 
where anesthesia was induced (2% Isoflurane in 2 L/min 100% oxygen for 5 to 10 
minutes) until no pedal reflex (movement from painful stimuli to foot) was observed in 
each animal. Animals continued to remain on anesthesia throughout the surgery. All 
animals were maintained at rectal temperature of 37 C during surgery and recovery 
using a feedback heating blanket. During the dMCAO procedure, an incision was made 
along the animal’s skull, through the skin, underlying connective tissue, and the 
temporalis muscle. Once the MCA was located, a craniotomy was drilled, exposing the 
dura right above the MCA. The dura was then punctured with a syringe and scrapped 
away, exposing the MCA, which was then cauterized. During sham surgery, the MCA 
was not cauterized once exposed, and otherwise the procedure is identical. The muscle 
and the skin was then folded back and the skin is sutured back together and mice are then 
injected with 25 mg/kg cefazolin (VWR #89149-888) and 1 mg/kg buprenorphine SR 
 
Figure 1: Experimental timeline: Diet feeding and behavior schedule relative to 
stroke. 
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(Zoopharm, Windsor, CO). The mouse was then placed under a heat lamp and monitored 
until it awoke. There are published studies that further describe the details of the dMCAO 
procedure (Doyle & Buckwalter, 2014; Doyle, Fathali, Siddiqui, & Buckwalter, 2012; 
Tamura, Graham, McCulloch, & Teasdale, 1981). 
 
Experimental design 
 Our study was a 2 x 2 design (dMCAO vs sham, HFD vs normal diet). In the text 
below, animals fed 6 weeks HFD that underwent dMCAO are called “dMCAO-HFD.” 
Animals fed 6 weeks normal diet that underwent dMCAO are called “dMCAO-normal 
diet.” Animals fed 6 weeks HFD that underwent sham surgery are called “Sham-HFD.” 
Animals fed 6 weeks normal diet that underwent sham surgery are called “Sham-normal 
diet.” Animals were sacrificed following behavioral assessment, 11 weeks after dMCAO 
or sham surgery. 
 
Immunohistochemistry 
After sacrificing, animals were perfused with 0.9% NaCl containing 10 U/mL 
Heparin, and brains were dissected out and drop fixed in 4% paraformaldehyde in 
phosphate buffer for 24 hours prior to being moved to 30% sucrose in phosphate-buffered 
saline. 40 m thick coronal brain sections were sectioned using a freezing sliding 
microtome (Microm HM430), collected sequentially in 12 tubes, and then stored in 
cryoprotectant medium (30% glycerin, 30% ethylene glycol, and 40% 0.5 M sodium 
phosphate buffer) at -20 C until further processed for immunohistochemistry. Standard 
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immunohistochemistry procedures were used to stain free floating sections. Sections 
were blocked with 3% donkey (Millipore, #S30-100mL), goat (Vector, #S-1000), or 
rabbit (Vector, #S-5000) serum for one hour. The brain sections were then incubated at 4 
C overnight in primary antibody: anti-GFAP (rabbit, 1: 10,000, Dako, #Z 0334), 
biotinylated anti-NeuN (mouse, 1:500, Millipore, #MAB377B), or anti-CD68 (rat, 1: 
1,000, Serotec, #MCA1957S). The following day, the brain sections were incubated for 
one hour in secondary antibody (1:500): anti-rabbit (goat, Vector, #BA-1000), or anti-rat 
(rabbit, Vector, #BA-4001), followed by ABC kit (Vector, #PK-6100) and 3,3′-
Diaminobenzidine tetrahydrochloride (Sigma, #D5905). Sections that were stained for 
NeuN were then further counterstained for cresyl violet. For cresyl violet counterstaining, 
mounted sections were dehydrated, submerged in cresyl violet, and rehydrated. All tissue 
sections were mounted on glass slides and cover slipped with entellan. 
 
Stroke size 
To assess stroke size, we took three different measurements for each animal: 
infarct area as a percent of contralateral hemisphere, ipsilateral hemisphere area as a 
percent of contralateral hemisphere area, and ipsilateral cortex area as a percent of 
contralateral cortex area. We immunostained 40 µm thick coronal sections spaced 240 
µm apart with NeuN and counterstained with cresyl violet to visualize the infarction. 
Sections started anterior to and finished posterior to the stroke core. We then imaged the 
sections with a PathScan Enabler IV (Meyer Instruments, Houston, TX).  For all three 
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measurements, ImageJ software (version 1.51c, 2017) was used to trace and quantify the 
desired area on each section. 
To analyze infarct size and to control for the edema of the ipsilateral hemisphere 
that is frequently observed after stroke, we calculated the infarct area as a percent of 
contralateral hemisphere ((infarct area/contralateral hemisphere area) x 100%). A 
researcher blinded to experimental groups of mice identified the five consecutive sections 
that most typically contained the infarcts seen in all the stroke animals. The infarct area 
as a percent of the contralateral hemisphere area for these five corresponding sections for 
all animal were calculated and then averaged together to get one average value per 
animal. 
To analyze the degree of ipsilateral atrophy, we calculated the ipsilateral 
hemisphere area as a percent of contralateral hemisphere area ((ipsilateral hemisphere 
area/contralateral hemisphere area) x 100%). This allowed us to compare the degree of 
atrophy in the ipsilateral hemisphere to the contralateral hemisphere. We measured the 
ipsilateral percent of contralateral for 12 sections per animal, spaced 480 m apart. We 
then took the average of the 12 sections per animal to get one average value for each 
animal. 
To analyze the degree of ipsilateral cortical atrophy, we calculated the ipsilateral 
cortex area as a percent of contralateral cortex area ((ipsilateral cortex area/contralateral 
cortex area) x 100%). This allowed us to analyze the degree of atrophy specifically in the 
ipsilateral cortex relative to the contralateral cortex. Due to time constraints, we took the 
measurements for the six middle sections of the 12 sections measured in the previous two 
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methods per animal. The six sections were spaced 480 m apart. We then took the 
average of the six sections per animal to get one average value for each animal. 
 
Imaging analysis 
To image for reactive microgliosis/infiltrating MDMs and reactive astrogliosis, 
we immunostained three sections spaced 480 m apart for CD68 and GFAP, 
respectively. The stained sections were imaged at 20x (Keyence Microscope BZ-X710, 
BZ-X viewer, Osaka, Japan). Two images were captured in the peri-infarct cortex for 
each of the three sections per animal, one medial to and one lateral to the stroke core. 
Each image was taken in the cortex one view field distance (543 µm) away from the 
stroke border. For sham animals, we took images of where we would expect to find the 
peri-infarct cortex if these animals had undergone stroke. We quantitatively assessed the 
area covered by staining in an unbiased and blinded fashion. In ImageJ, images were set 
to an 8-bit color (black and white), and quantified at a less inclusive threshold and a more 
inclusive threshold. The less inclusive threshold encompassed only the soma while the 
more inclusive threshold included both the soma and processes. We then took the average 
of the three medial peri-infarct images for every animal to calculate the average relative 
percent area covered by GFAP in the medial peri-infarct area for each animal. We also 
did the same for the lateral peri-infarct images. Finally, we took the average of the 
relative percent area covered by GFAP in the medial peri-infarct area and the latera peri-
infarct area per animal. This gave us an overall relative percent area covered by GFAP 
per animal. These values from animals in the same group were then averaged together to 
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get an overall relative percent area covered by GFAP for each group. The same steps 
were done for both the less inclusive images and the more inclusive images. 
 
Behavioral tasks 
 Y-maze task 
The Y-maze task is a spontaneous alternation behavior task and has been used in a 
variety of studies to measure hippocampal-dependent spatial memory in mice (Conrad, 
Galea, Kuroda, & McEwen, 1996; Fu et al., 2017; Reisel et al., 2002). Since this task 
requires mice to remember previous events, it is possible that this task may also involve 
other aspects of memory such as recognition. This task allows each mouse to freely 
explore a maze that consists of three arms, labeled A, B, and C (Figure 2). Mice tend to 
explore a novel arm 
rather than the previous 
two arms that they 
explored (Stanford 
Medicine, 2017). For 
example, if a mouse 
went into arm A and arm 
B for its two previous 
choices, it would have 
preference to next go 
into arm C, since it had 
 
Figure 2: Schematic of Y-maze paradigm. Three arms 
labeled A, B and C. 
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not explored it in the previous two choices. We defined “alternation” as when the mouse 
enters an arm that is different from the last two choices. One hour before testing, the mice 
were moved to the testing room to allow them to acclimate to the environment. Each 
mouse was put into the Y-maze and given 5 minutes to freely explore. The 5-minute task 
was video recorded. The maze was cleaned with 70% ethanol between each mouse to 
prevent olfactory cues from affecting the behavior of the animals. A blinded researcher 
scored each 5-minute video, recording which arms and which order each mouse entered. 
The percent alternation was calculated as the proportion of choices differing from the 
previous two choices (# of choices differing from the previous two/ total # of alternation 
opportunities). The total # of alternation opportunities is calculated as the total entries 
minus two. Each mouse was tested on the Y-maze 1 day prior to surgery, 1, 4, 7, and 11 
weeks after surgery. 
 Novel object task 
The novel object task is a task used to test recognition memory (Leger et al., 
2013), which includes the ability to recall previously explored objects, in mice. This task 
relies on the innate preference of mice to explore novel objects (NO) instead of objects 
they have explored before (Leger et al., 2013). Using this task, we can assess the memory 
of each mouse by looking at how much they explore the NO compared to a former object 
(FO). In phase 1 of this task, each mouse was put into an arena with two different but 
similar objects placed in the center of the arena with equal distances from the walls 
(Figure 3). Each mouse was given 5 minutes to freely explore the arena and the objects 
before being put back into its cage. For phase 2 of the task, one of the two objects in the 
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arena is replaced with a new object that is also different but similar to the object that is 
left in the arena (Figure 3). 
Three to four hours after 
phase 1, each mouse was put 
into the arena again and 
allowed to explore freely for 
5 minutes before being put 
back in its cage. The arena 
and object were wiped down 
with 70% ethanol between 
each trial to prevent 
olfactory cues from affecting 
the behavior of each mouse. 
 Each 5-minute trial was video recorded and a blinded researcher watched each 
video and recorded the amount of exploration done by each mouse. We defined 
“exploration” of the objects in two ways: the number of times the mouse entered within 2 
cm of the object and the total amount of time the mouse spent within 2 cm of the object. 
We refer to the space within 2 cm of the object the “exploratory zone”. Object 
recognition was quantified using a discrimination index (DI), defined as 100 × [(NO 
Time − FO Time)/(NO Time + FO Time)]. Each mouse was tested on the NO task 1 day 
prior to surgery (baseline), and 1, 4, 7, 11 weeks after surgery. 
 
 
Figure 3: Schematic of Novel Object Task 
paradigm. NO arena consists of two different but 
similar objects. Any area inside the zone outlined 
by the yellow tape is 2 cm or less from the object. 
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Statistical analysis 
All values are shown as means  standard error of the mean (SEM). When only 
two groups were compared, a Student’s t-test was used. When multiple groups were 
compared, we used an ordinary one-way analysis of variance (ANOVA) or two-way 
ANOVA and a Tukey’s multiple group comparisons test, Sidak’s multiple group 
comparisons test, or Dunnett’s multiple group comparisons test as appropriate for post-
hoc analysis. Data analysis was performed with GraphPad Prism 7 software. Parametric 
tests were chosen as we assumed all our datasets followed a normal distribution. We also 
utilized the Grubb’s outlier test to identify any outliers within our dataset. We did not 
exclude any outliers from the analysis of our data set. Lastly, we performed multiple 
regression analysis to assess the effect of two independent variables on different 
dependent variables. All animals were randomized, concealed, and blinded to the 
experimenters. Samples that were defective due to tissue processing were also excluded 
from our analysis. 
 
RESULTS 
 
HFD-fed animals experience weight gain while normal diet-fed animals maintain 
constant weight 
 From multiple preliminary studies, we know that animals fed HFD consistently 
gain more weight than animals fed normal diet. In a previous study, we kept mice on 
either a HFD or normal diet for 6 weeks. Overall, a repeated measures two-way ANOVA 
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showed a significant difference in percent of original body weight between the two diet 
groups (p < 0.0001). A Sidak's multiple comparisons post-hoc test suggested a significant 
difference in percent original body weight gain at 1,2, 4, 5, and 6 weeks between the 
HFD group and normal diet 
group (week 1, p < 0.001; 
week 2, 4, 5, 6, p < 0.0001; 
Figure 4). Six weeks of 
HFD caused 136.7% 
increase in weight while 6 
weeks of normal diet 
caused only 105.5% weight 
gain, which is a normal low 
level of weight gain for this 
normal diet (The Jackson 
Laboratory, 2018). Therefore, we concluded that 6 weeks of HFD is sufficient to induce 
significant weight gain. 
Prior to sacrifice at 11 weeks after surgery, the weight of each animal was 
measured (Figure 5). Using a one-way ANOVA, we found significant differences in 
weight at 11 weeks after surgery between the four groups (p < 0.0001). A Tukey’s 
multiple comparison post-hoc test demonstrated that dMCAO-HFD animals weighed 
significantly more than dMCAO-normal diet animals (p < 0.0001) while Sham-HFD 
 
Figure 4: The percent of original weight for normal 
diet-fed animals and HFD-fed animal at weeks 1, 2, 3, 
4, 5, and 6 from another previous study. p *** < 
0.001, p **** < 0.0001, normal diet vs. HFD. 
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animals weighted 
significantly more than 
Sham-normal diet animals (p 
< 0.0001).  However, there 
was no difference in weight 
between dMCAO-HFD vs. 
Sham-HFD and dMCAO-
normal diet vs. Sham-normal 
diet. In conclusion, we 
demonstrated that the type of 
diet but not the type of 
surgery had a significant 
effect on weight at 11 weeks 
after surgery. 
 
Following stroke HFD-fed animals have an earlier onset of cognitive deficit 
compared to normal diet-fed animals 
To test our hypothesis that HFD-fed animals develop earlier and/or more severe 
cognitive deficits during the chronic period after stroke compared to normal diet-fed 
animals, we utilized the Y-maze task, a task used to assess memory in mice at 1, 4, 7, and 
11 weeks after surgery. Overall, our results suggest that HFD-fed animals experience an 
 
Figure 5: The weight (g) of Sham-normal diet, 
Sham-HFD, dMCAO-normal diet, and dMCAO-
HFD groups 11 weeks after surgery. 
p****<0.0001. 
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earlier onset of cognitive deficits after stroke. Using a two-way ANOVA, we found 
significant differences in percent alternation between the four groups (p < 0.0001), but no 
difference in percent alternation between time points. Using a Dunnett’s multiple 
comparisons post-hoc test (with Sham-normal diet animals as the control group), we 
found no significant difference in percent alternation between Sham-HFD and control 
animals at all time points (Figure 6), suggesting that HFD alone does not significantly 
affect cognition at any of these time points. At 1 week after surgery, both the dMCAO-
HFD and dMCAO-normal diet group did not perform differently from the control group, 
suggesting no deficits at 1 week after stroke in both diet groups. Interestingly, the 
dMCAO-HFD group did much worse at 4 weeks (p < 0.01) while the dMCAO-normal 
diet group still did not perform much differently from the control group at this time point. 
 
Figure 6: The percent Y-Maze alternation in Sham-normal diet, Sham-HFD, 
dMCAO-normal diet, and dMCAO-HFD groups at baseline prior to surgery and 
at 1, 4, 7, 11 weeks after surgery. p ** < 0.01, p *** < 0.001, compared to Sham-
normal diet; p ## < 0.01, compared to dMCAO-normal diet. 
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This excitingly suggests that HFD-fed animals but not normal-fed animal experienced 
memory deficits at just 4 weeks after stroke. As expected, both the dMCAO-normal diet 
and dMCAO-HFD group had worse deficits at 7 weeks compared to the control group 
(dMCAO-normal diet vs. control, p < 0.01; dMCAO-HFD vs. control, p < 0.001), which 
we continued to observe at 11 weeks (dMCAO-normal diet vs control, p < 0.001; 
dMCAO-HFD vs control, p < 0.001). A Tukey’s multiple comparisons post hoc-test 
suggested that HFD-fed animals performed worse than dMCAO-normal diet animals at 4 
weeks after surgery (p < 0.01), but not at 1, 7, or 11 weeks after surgery. In conclusion, 
we demonstrated that HFD led to deficits in memory earlier after stroke (at 4 weeks 
instead of 7 weeks). Note that although HFD did not lead to more severe deficits at 7 
weeks and beyond compared to normal diet, the Y-maze task has a floor effect–mice 
cannot do worse than random movement. Therefore, this experimental design only allows 
us to test the onset of deficits but not whether they are worse in one impaired group than 
another. 
In addition to utilizing the Y-maze task, we also used the NO task to test memory 
after dMCAO in both diet groups at weeks 1, 4, 7, 11 after surgery. Overall, a two-way 
ANOVA suggested significant differences in percent NO contacts between the four 
groups (p < 0.0001) and between time points (p < 0.05). Using a Dunnett’s multiple 
comparisons post-hoc test (with the Sham-normal diet group as the control), we found 
that Sham-HFD and control animals did not have a significant difference in percent of 
NO contacts at all time points, similar to what we found in the Y-maze task (Figure 7). 
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This suggests that recognition memory is also not affected by diet alone at these time 
points. Surprisingly, we observed worse performance in dMCAO-HFD animals 
compared to the control group at just 1 week after surgery (p < 0.05), while dMCAO-
normal diet did not perform differently than the control group. The onset of deficits was 
seen much earlier using this task, whereas the deficits were seen later in the Y-maze task 
(at week 4). This deficit in the dMCAO-HFD group persisted at 4 weeks after stroke (p < 
0.01), whereas the dMCAO-normal diet group continued to perform similarly to the 
control group at this time point. Interestingly, we started to observe a deficit in dMCAO-
normal diet animals (p < 0.05) but not dMCAO-HFD animals at 7 weeks. Furthermore, 
both the dMCAO-normal diet and dMCAO-HFD animals performed similar compared to 
the control animals at 11 weeks. A Tukey’s multiple comparisons post-hoc test showed 
no significant differences between dMCAO-HFD and dMCAO-normal diet animals at 
 
Figure 7: The percent NO contacts in Sham-normal diet, Sham-HFD, dMCAO-
normal diet, and dMCAO-HFD groups at baseline prior to surgery and at 1, 4, 7, 
11 weeks after surgery. p * < 0.05, p ** < 0.01, compared to Sham-normal diet. 
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any time points. In conclusion, we demonstrated that HFD caused earlier onset of deficits 
in cognition after stroke (at 1 and 4 weeks vs. 7 weeks). Both diet groups eventually 
experienced improved memory, at 7 weeks for dMCAO-HFD animals and 11 weeks for 
dMCAO-normal diet animals, suggesting that both diet groups experienced spontaneous 
recovery in the NO cognitive task.  
Another method of measuring exploration in the NO task is to consider the total 
time spent at each object, which is the total time that each mouse spent within the 
exploratory zones associated with each object. To analyze our dataset using the two-way 
ANOVA, we had to delete the data from the baseline time point for all groups, since we 
were missing all the data for the Sham-HFD and Control group. Using a two-way 
ANOVA after this exclusion, we found significant differences in percent time spent near 
 
Figure 8: The percent time near NO in Sham-normal diet, Sham-HFD, dMCAO-
normal diet, and dMCAO-HFD groups at baseline prior to surgery and at 1, 4, 7, 
11 weeks after surgery. 
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NO between the four groups (p < 0.05) and between time points (p < 0.05). A Dunnett’s 
multiple comparisons post-hoc test (with Sham-normal diet animals as the control) 
suggested no significant differences between the different groups and the control group at 
every time point. Overall, the percent time near NO seemed to be variable and we did not 
see any expected patterns (Figure 8). In fact, we found negative values in the percent time 
spent near NO in different groups at various time points, which demonstrates that on 
average, these mice spent more time near the FO than near the NO. 
 
Stroke size does not differ between dMCAO-HFD animals and dMCAO-normal diet 
animals 11 weeks after dMCAO 
To see whether this earlier onset of cognitive-deficits observed in the dMCAO-
HFD animals was associated with increased ischemic brain tissue damage, we measured 
the infarct size, the degree of ipsilateral hemisphere atrophy, and degree of ipsilateral 
cortex atrophy at 11 weeks after stroke. As mentioned earlier, we calculated the average 
infarct area as a percent of contralateral hemisphere in five brain sections per animal to 
control for ipsilateral edema typically observed in our dMCAO stroke model. Using an 
unpaired t-test, we found no difference in the infarct as a percent of the contralateral 
hemisphere between the dMCAO-normal diet group and dMCAO-HFD group (Figure 9). 
While performing the infarct area, we noticed that many of the tissue sections in 
most animal did not have obvious stroke cores and that most of the areas that were 
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supposed to contain the stroke core were very small perhaps due to brain remodeling over 
the 11 weeks since stroke (Z. G. 
Zhang & Chopp, 2015). This 
made it difficult to accurately 
measure the infarct area in each 
of those sections. Furthermore, 
we qualitatively noticed that the 
tissue surrounding the infarct 
area tended to curve in, making it 
even more difficult to predict 
where the infarct area would be 
in those sections missing the 
stroke core. 
 Because of the difficulty of accurately measuring the infarct area with this 
method, we assessed brain tissue damage by measuring the remaining ipsilateral 
hemisphere area as a percent of the contralateral hemisphere area. This method seemed to 
produce less subjective results and allowed us to assess the degree of ipsilateral 
hemisphere atrophy, which is more ideal since we qualitatively noticed that the ipsilateral 
hemisphere tended to be smaller than the contralateral hemisphere. We excluded the 
areas of ventricles in our measurements since ventricular sizes are known to increase 
after stroke when there is brain atrophy. Using an unpaired t-test, we also found no 
 
Figure 9: The infarct area as a percent of 
contralateral hemisphere area for dMCAO-
normal diet and dMCAO-HFD group. 
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difference in the ipsilateral hemisphere area as a percent of contralateral hemisphere area 
between the dMCAO-normal diet group and dMCAO-HFD group (Figure 10).  
Since we did not find 
a difference by measuring 
the degree of atrophy in the 
entire ipsilateral hemisphere, 
we decided to focus our 
analysis on the cortical 
regions of the tissue sections. 
In the dMCAO stroke model, 
the infarct is in the cortex. 
Therefore, we decided that 
assessing the degree of 
ipsilateral cortical atrophy by 
calculating the ipsilateral cortical area as a percent of contralateral cortical area would 
give us results that would more accurately reflect the amount of damage caused by 
dMCAO. An unpaired t-test suggested no difference in the ipsilateral cortical area as a 
percent of the contralateral cortical area between the dMCAO-normal diet group and the 
dMCAO-HFD group (Figure 11). In conclusion, we demonstrated that diet does not 
influence infarct size or the degree of ipsilateral tissue atrophy at 11 weeks after stroke. 
 
 
Figure 10: Ipsilateral hemisphere area as a 
percent of contralateral hemisphere area for the 
dMCAO-normal diet and dMCAO-HFD diet 
group. 
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Diet does not dramatically affect the degree of astrogliosis 11 weeks after dMCAO 
To characterize the 
neuroinflammatory 
response at 11 weeks after 
dMCAO or sham in 
animals on HFD or normal 
diet, we stained brain 
sections for GFAP and 
measured the percent of 
the peri-infarct area 
covered by this cell 
marker. GFAP is a surface 
marker found in astrocytes that is dramatically upregulated after neural insult and is 
therefore an indicator of reactive astrogliosis (Fawcett & Asher, 1999). First, we applied 
a less inclusive threshold, which only included the most intense areas of GFAP reactivity, 
which is generally limited to cell bodies. Using a one-way ANOVA on our data obtained 
from less inclusive thresholding, we found significant differences in relative percent of 
the peri-infarct area covered by GFAP between the four groups (p < 0.01). A Dunnett’s 
multiple comparisons post-hoc test (using Sham-normal diet animals as the control) 
suggested that the relative percent peri-infarct area covered by GFAP in dMCAO-HFD is 
significantly higher than control (p < 0.01), with the dMCAO-HFD group having an 
  
Figure 11: Ipsilateral cortical area as a percent of 
the contralateral cortical area for dMCAO-normal 
diet and dMCAO-HFD group. 
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8.47-fold larger percent area covered by GFAP (Figure 12). However, there were no 
significant differences in the percent area covered by GFAP between the dMCAO-normal 
diet group and 
control. We also 
found no difference 
between the Sham-
HFD and the control 
group. To test for 
differences in GFAP 
staining between all 
the groups, we used 
a Tukey’s multiple 
comparisons post-hoc test and found no differences in percent area covered by GFAP 
between the dMCAO-HFD and dMCAO-normal group. In conclusion, we demonstrated 
that HFD leads to increased coverage of the peri-infarct area by astrocytic cell bodies at 
11 weeks after stroke. We also show that stroke or HFD alone does not lead to increased 
coverage of astrocytic cell bodies at this time point. 
To see if there were differences in the morphology of astrocytes in the peri-infarct 
area between the four groups, we also utilized a more inclusive threshold, which includes 
both GFAP-positive cell bodies and processes. A one-way ANOVA suggested a 
significant difference in percent area covered by GFAP between the four groups (p < 
 
Figure 12: Relative percent area GFAP in Sham-normal 
diet, Sham-HFD, dMCAO-normal diet, and dMCAO-HFD 
groups using less inclusive thresholding. p ** < 0.01, 
compared to Sham-normal diet group. 
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0.001). Using a Dunnett’s multiple comparisons post-hoc test (with Sham-normal diet 
animals as the control), we discovered a significant increase in percent area covered by 
GFAP in both the dMCAO-HFD and dMCAO-normal diet group compared to the control 
group (dMCAO-normal diet vs control, p < 0.01; dMCAO-HFD vs control, p < 0.001; 
Figure 13). The percent area covered by GFAP in dMCAO-HFD animals was 5.4 folds 
higher than the those 
found in control, 
while the percent 
area covered by 
GFAP in dMCAO-
normal diet animals 
was 3.9 folds higher 
than those found in 
control. This is 
interesting, since we 
did not observe a 
significant increase in percent area covered by GFAP in dMCAO-normal diet animals 
using a less inclusive threshold. Like our results from less inclusive thresholding, we 
found no difference between the Sham- HFD group and the control group. A Tukey’s 
multiple comparisons post hoc-test revealed no differences in percent area covered by 
GFAP between the dMCAO-HFD and dMCAO-normal group. In conclusion, we 
demonstrated that astrocytes in the peri-infarct area adopt a more reactive phenotype at 
 
Figure 13: Relative percent area GFAP in Sham-normal 
diet, Sham-HFD, dMCAO-normal diet, and dMCAO-HFD 
groups using more inclusive thresholding. p * < 0.05, p 
*** < 0.001 compared to Sham-normal diet group. 
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11 weeks after stroke in both diet groups, and that HFD alone does not lead to a larger 
degree of reactive morphology in astrocytes. 
 
Microglia/MDM activation is increased in HFD-dMCAO animals compared to 
dMCAO-normal diet animals 11 weeks after stroke 
To characterize the microglial response and degree of MDM infiltration at 11 
weeks after dMCAO or sham, we stained tissue sections with CD68. CD68 is a surface 
marker known to be expressed on phagocytotic microglia and macrophages, and is an 
indicator of reactive microgliosis/infiltrating MDMs. To include just the cell bodies of 
microglia/MDMs in our analysis, we used a less inclusive thresholding. A one-way 
ANOVA showed significant differences in the relative percent area covered by CD68 
between the four groups at 11 weeks after surgery (p < 0.01). A Dunnett’s multiple 
comparisons post-hoc test, comparing each group to the Sham-normal diet group 
(control), demonstrated a significantly larger relative percent area covered by CD68 in 
the dMCAO-HFD compared to the control group (p < 0.01), as expected (Figure 14). 
There were no differences between the dMCAO-normal diet group and the control group. 
We also did not find any differences between Sham-HFD and control animals. Using a 
Tukey’s multiple comparison post-hoc test, we found a significantly larger relative 
percent area covered by CD68 in the dMCAO-HFD group compared to the dMCAO-
normal diet group (p < 0.05). In conclusion, we demonstrated that HFD leads to increased 
coverage of the peri-infarct area by cell bodies from activated microglia/MDMs at 11 
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weeks after stroke. Furthermore, stroke or HFD alone does not lead to increased CD68-
stained cell bodies at this time point, suggesting that stroke and HFD interact to produce 
increased microglia/MDM numbers in dMCAO-HFD mice at 11 weeks after stroke. 
When we used a one-way ANOVA on our data obtained from more inclusive 
thresholding, we found significant differences in the relative percent of peri-infarct area 
covered by CD68 between the four groups at 11 weeks after surgery (p < 0.01). Followed 
this up with a Dunnett’s multiple comparisons post-hoc test (with the control group being 
the Sham- normal diet animals), we demonstrated a significant difference between the 
relative percent area 
covered by CD68 
between the dMCAO-
HFD and control 
animals (p < 0.01; 
Figure 15). We did not 
find a difference 
between dMCAO-
normal diet and control 
animals nor between the 
Sham-HFD and control 
animals. A Tukey’s multiple comparisons post-hoc test revealed significantly higher 
relative percent covered by CD68 in the dMCAO-HFD group compared to the dMCAO-
 
Figure 14: Relative percent area CD68 in Sham-normal 
diet, Sham-HFD, dMCAO-normal diet, and dMCAO-
HFD groups using less inclusive thresholding. p ** < 
0.01, compared to Sham-normal diet group; p # < 0.05, 
compared to dMCAO-normal diet group. 
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normal diet (p < 0.05). These results suggest that HFD leads to a larger degree of reactive 
morphology in active microglia/MDMs in the peri-infarct area at 11 weeks after stroke. 
We also found that stroke or HFD alone does not lead to increased reactive phenotype at 
this time point.  
 
Body weight does not correlate with the degree of cortical atrophy at 11 weeks after 
stroke 
 We next asked if there was a relationship between weight at sacrifice and the 
degree of ischemic brain damage (Figure 16). Since we thought the ipsilateral cortex area 
as a percent of 
contralateral cortex area 
most accurately 
reflected the tissue 
damage caused by 
dMCAO, we compared 
the data from this 
method to the weight of 
animals at sacrifice 
using multiple 
regression analysis. 
There was no relationship between mouse body weight and degree of cortical atrophy in 
 
Figure 15: Relative percent area CD68 in Sham-normal 
diet, Sham-HFD, dMCAO-normal diet, and dMCAO-
HFD groups using more inclusive thresholding. p ** < 
0.01, compared to Sham-normal diet group; p # < 0.05, 
compared to dMCAO-normal diet group. 
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the dMCAO-HFD group. This was also the case for the normal diet group, indicating 
there is not a correlation between body weight and infarct size 11 weeks after dMCAO in 
either diet condition. Furthermore, we also found no relationship between weight and 
cortical atrophy after pooling the data together from dMCAO-HFD and dMCAO-normal 
diet groups, confirming no correlation between weight and cortical atrophy regardless of 
diet. From the small R squared values, we infer that the regression model only explains a 
small amount of the variability between weight and cortical atrophy in the dMCAO-HFD 
group, dMCAO-normal diet group, and the pooled group.  
 
Body weight is correlated with Y-maze performance at week 4 and 7 after stroke 
To see whether diet affected the relationship between weight measurements taken 
at sacrifice and 
cognition at different 
time points, we also 
utilized a multiple 
regression analysis 
(Figure 17). At every 
time point after stroke 
at which cognitive 
performance was 
measured, separate regression lines for both the dMCAO-HFD and dMCAO-normal diet 
 
Figure 16: Multiple regression analysis between 
ipsilateral cortex area percent of contralateral cortex area 
and weight for dMCAO-normal diet and dMCAO-HFD 
group. 
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group did not have slopes significantly different from zero, indicating there was no 
correlation between weight and cognition in both diet groups at all time points after 
stroke. However, when we pooled the data together from the dMCAO-HFD and 
dMCAO-normal diet group for each time point, we found at 4 weeks after stroke, there 
was a significant negative relationship between weight and Y maze performance (R 
squared = 0.4858, p < 0.001). This was also true at 7 weeks after stroke (R squared = 
0.3676, p < 0.01). Taken together, these results suggest that cognition at 4 and 7 weeks 
after stroke tend to decrease with increasing weight, regardless of diet. However, from 
the relatively small R squared values at the different time points, we also infer that the 
regression model only explains a relatively small amount of the variability between 
weight and cortical atrophy in the dMCAO-HFD group, dMCAO-normal diet group, and 
 
 
Figure 17: Percent alternation for Y-maze task at weeks 1, 4, 7, 11 after surgery 
vs weight at sacrifice for dMCAO-normal diet and dMCAO-HFD group. 
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the pooled group at different time points. At all time points, there were no significant 
difference between the slopes of the regression equations for the dMCAO-HFD and 
dMCAO-normal diet group, suggesting that the relationship between weight and 
performance on the Y maze did not depend on type of diet. 
 
Body weight is not correlated with the degree of astrogliosis 11 weeks after stroke 
 Next, we asked whether there was a relationship in either diet condition between 
the degree of 
astrogliosis in the 
peri-infarct area 
and body weight at 
sacrifice (Figure 
18). We utilized the 
relative percent 
peri-infarct area 
covered by GFAP measured with a more inclusive threshold to compare with weight 
since more inclusive thresholding measured the area covered by both cell body and cell 
processes expressing GFAP, therefore being a better measure of reactive astrogliosis. 
Using a multiple regression analysis, we found no significant correlation between the 
degree of astrogliosis and body weight in both the dMCAO-HFD and the dMCAO-
normal diet group, suggesting no correlation between body weight and the degree of 
 
Figure 18: Relative percent area GFAP with more inclusive 
thresholding vs weight for dMCAO-normal diet and 
dMCAO-HFD group. 
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astrogliosis in both diet conditions at 11 weeks after stroke. After pooling the data from 
dMCAO-HFD and dMCAO- normal diet group together, we still did not find an 
association between body weight and the degree of astrogliosis, suggesting no correlation 
between these two variables regardless of the type of diet. The small R squared values 
found in the dMCAO-HFD group, dMCAO-normal diet group, and the pooled group 
demonstrated that the regression model can only explain a small amount of the variability 
between weight and degree of astrogliosis. Since there was no significant difference 
between the slopes of the regression lines for the dMCAO-HFD group and the dMCAO-
normal diet group, we concluded that the correlation between weight and degree of 
astrogliosis at 11 weeks after stroke did not depend on the type of diet. 
 
Body weight is not correlated with the degree of microgliosis/infiltrating MDMs 11 
weeks after stroke 
Finally, to assess the effects of diet on the correlation between the degree of 
reactive microgliosis/infiltrating MDMs in the peri-infarct area and the weight at 
sacrifice, we also utilized a multiple regression analysis (Figure 19). Again, we used our 
results obtained from more inclusive thresholding to compare with weight. We found a 
significant positive correlation between body weight and degree of reactive microgliosis 
in the dMCAO-HFD group (R squared = 0.6559, p < 0.01), suggesting that the degree of 
microgliosis increased with body weight at 11 weeks after stroke in animals on HFD. 
However, we did not see an association between weight and degree of microgliosis in the 
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dMCAO-normal diet group. Pooling the data together from dMCAO-HFD and dMCAO- 
normal diet group gave us a positive association between body weight and degree of 
microgliosis (R squared = 0.4069, p < 0.01). This suggests that without considering the 
effects of diet, the degree of microgliosis increase with body weight. We also found a 
significant 
difference between 
the slopes of the 
regression lines for 
the dMCAO-HFD 
group and the 
dMCAO-normal 
diet group (p < 
0.01), demonstrating that the relationship between weight and degree of microgliosis at 
11 weeks after stroke depends on the type of diet. 
 
Outlier tests 
To test for outliers in our datasets, we utilized the Grubb’s test. We found one 
animal in the Sham-HFD group whose weight was an outlier when analyzing weight at 
11 weeks after surgery. We did not find any outliers in our datasets used for the different 
methods of calculating ischemic brain tissue damage. We found one animal in the 
dMCAO-HFD group whose relative percent area GFAP was an outlier when analyzing 
 
Figure 19: Relative percent area CD68 with more inclusive 
thresholding vs weight for dMCAO-normal diet and 
dMCAO-HFD group. 
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the relative percent of peri-infarct area covered by GFAP using less inclusive 
thresholding. We did not exclude any outliers since we were unsure if these data points 
were due to biological variability or experimental errors. 
 
DISCUSSION 
 
Ischemic stroke is a neurological disease that has high morbidity rates and leads 
to the onset of cognitive deficits. Obesity is one of the risk factors for ischemic stroke, 
and it is thought that a larger neuroinflammatory response in obese patients can be the 
cause of worse stroke outcomes. In particular, stroke patients who are obese have worse 
cognitive deficits (P. Li et al., 2016; Lu et al., 2016; Yong Zhang et al., 2012) However, 
very little is known about the mechanisms, such as neuroinflammation, which determine 
the onset of cognitive deficits in obese patients, especially in the chronic phase after 
stroke. Therefore, we conducted a study to test whether obese mice had an earlier onset 
of delayed-cognitive deficits compared to normal weight mice, and whether this 
increased cognitive deficit was associated with larger strokes and increased 
neuroinflammatory response during the chronic phase. In summary, we found that HFD-
fed animals had an earlier onset of cognitive deficits compared to normal diet-fed animals 
after stroke. We also found that both diet groups had persistent reactive astrogliosis in the 
chronic phase after stroke while reactive microgliosis was present only in the HFD-fed 
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animals during that time point, suggesting that HFD led to a larger persistence of 
neuroinflammation. 
Consistent with the findings of Doyle et al. (2015), we demonstrated that normal 
diet-fed animals had significant deficits in memory at 7 weeks after stroke compared to 
Control animals, as suggested by the results from the Y-maze task. It is noteworthy that 
we observed similar deficits on the Y-maze task using our dMCAO stroke model, 
whereas the study by Doyle et al. (2015) utilized the distal middle cerebral artery 
occlusion with hypoxia (DH) stroke model, indicating this task is able to detect cognitive 
deficits in the chronic phase after stroke in multiple rodent models of ischemia. Memory 
deficits were also evident in HFD-fed mice at the 7-week time point, as expected. 
Interestingly, we saw the onset of memory deficits in HFD-fed animals at just 4 weeks 
after stroke, whereas normal diet-fed animals did not have this deficit at this time point. 
These findings suggest that HFD-fed animals tend to have an earlier onset of memory 
deficits compared to normal weight animals after stroke. At 11 weeks after stroke, we 
saw that mice in both diet conditions continued to perform worse significantly worse in 
the Y-maze compared to the non-stroke normal diet animals, suggesting that this delayed-
cognitive deficit persists beyond the 7-week time point described in Doyle et al.’s (2015) 
study.  
In addition, we demonstrated that heavier animals tend to have more severe 
cognitive deficits than lighter animals at 4 and 7 weeks after stroke. While we found that 
HFD-fed mice on average experienced cognitive deficits earlier after stroke at 4 weeks 
compared to normal-diet mice, the heavier mice in the dMCAO-HFD group did not 
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necessarily have a larger deficit compared to the other animals in that same group at that 
time point. This may suggest that once the animals reach a certain level of adiposity, a 
further increase in body weight does not worsen cognitive deficits even further. These 
results may also be due to a flooring effect in the behavioral task, where the performance 
in the Y-maze does not accurately reflect the degree of deficits once the animals perform 
worse than a certain level. Finally, it is important to note that all four groups had a 
percent alternation of around 50% at baseline and week 1 after surgery, suggesting that 
they were not performing above chance. Therefore, it makes it more difficult to interpret 
whether the significant decreases in percent alternation at later time points truly reflect 
worse performance. 
Our findings from the novel object recognition memory task were largely 
consistent with our findings from the Y-maze task. Using the NO task, we found a 
significant deficit in normal diet-fed animals at 7 weeks after stroke compared to the 
Control animals. Interestingly we saw an even earlier deficit in HFD-fed animals at just 1 
week after stroke, which may suggest that certain aspects of cognitive functioning, such 
as recognition memory, may be affected earlier by obesity than other aspects like spatial 
memory. While there is evidence that stroke can affect different aspects of cognitive 
functions, like executive functioning, memory, and learning (Al-Qazzaz, Ali, Ahmad, 
Islam, & Mohamad, 2014) there is no clear evidence directly supporting that decline in 
recognition memory in particular occurs earlier than the decline in spatial memory. As 
mentioned earlier, animals may also utilize other cognitive skills when performing in the 
Y-maze such as recognition memory, which is what the NO task supposedly measures. 
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This makes it uncertain whether our results suggest an earlier onset of deficit in one 
component of cognition compared to another. This deficit in recognition memory 
continued to be seen in HFD-fed animals at 4 weeks after stroke. 
Surprisingly, performance of obese animals on the NO task had improved to 
control levels at 7 and 11 weeks after stroke, while normal diet-fed mice did not show 
improvements until 11 weeks. This may suggest that both normal weight and obese 
animals experienced a functional recovery in recognition memory during the chronic 
phase, and that obese animals experienced this recovery earlier than normal weight mice. 
This contradicts our findings from the Y-maze task, where we found an onset of 
cognitive deficits at 7 weeks in HFD-fed animals and continuation of this deficit at 11 
weeks in both diet groups. 
We hypothesize that the NO task may not be a reliable behavioral paradigm for 
testing recognition memory deficits in our dMCAO stroke model. Many different factors 
may confound the results such as any differences in the physiology and genetics of the 
animals or the environment of the animals and result in variability in these behavioral 
tasks (Nature Neuroscience, 2009; Sousa N., Almeida O. F. X., & Wotjak C. T., 2006). 
Examples of factors in the environment that can change animal behavior include the way 
the animals are handled by the investigator, the lighting during the behavioral tasks, and 
the time of the day the task was done (Sousa N. et al., 2006). Because of this, there is 
considerable natural variability in rodent performance in behavioral studies, and it is 
difficult to develop a task that is both sensitive enough and reliable enough to measure 
changes in the behavior of interest. 
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For instance, in the NO task, the methodology we used to interpret and score 
object recognition may not have accurately reflected exploratory behavior in mice. After 
scoring the number of entries into the exploratory zone of each object within a 5-minute 
span for each mouse at various time points, we noticed that the amount of time spent 
inside the exploratory zone during each entry were variable between mice, where some 
mice spent more time inside the exploratory zone while others spent less. Therefore, we 
thought that timing the total time each mouse spent at each object within the exploratory 
zone might give us different results. However, the results from this way of measuring 
exploration did not reflect what we found measuring the number of entries into the 
exploratory zone. In fact, it seemed that at a variety of time points, mice from different 
groups preferred to spend more time at the FO compared to the NO, which is contrary to 
normal mouse exploratory behavior.  
One explanation for these unexpected results obtained by tracking the total 
amount of time spent at each object could be the way we defined exploratory behavior. 
We defined exploration as the time any part of the mouse, except for the tail, was within 
the exploratory zone, even when the mouse was facing away from the object or sitting on 
top of the object. Many researchers agree that climbing on the object by itself is not 
considered exploratory behavior (Leger et al., 2013). Some studies defined exploration as 
“directing the nose at a distance 2 cm or less to the object and/or touching it with the 
nose” (Antunes & Biala, 2012), which can be subjective, unless an operational definition 
was established for “directing the nose at the object”. In fact, some studies further define 
“directing the nose” as when the animal’s head is within 45 degrees of the object (Gaskin 
 
 
 
 
66 
 
 
et al., 2010; Mumby, Glenn, Nesbitt, & Kyriazis, 2002). In the future, we would like to 
adjust our operational definition of exploration to include a more specific and restrictive 
set of criteria than just when the animal is within 2 cm of the object, which might reduce 
variability and more accurately measure exploratory behavior. Another possibility is that 
there is no true difference in recognition memory between all four of the groups in our 
study. 
We did not find any significant difference in performance at any of the time 
points in both the Y-maze task and the NO task between the HFD-fed animals and 
normal diet-fed animals that underwent sham surgery, suggesting that diet alone does not 
contribute to cognitive deficits. This is inconsistent with rodent studies showing that diet-
induced obesity causes deficits in different cognitive processes including spatial memory 
and learning (Jurdak, Lichtenstein, & Kanarek, 2008; Nguyen, Killcross, & Jenkins, 
2014). The discrepancies between our findings and those studies are most likely due to 
the differences in the composition of the diets, length of feeding period, and types of 
behavioral tasks used. For example, one study that found a memory deficit in obese 
animals used supplemental sugar to induce obesity in rats and used the Morris Water 
Maze to assess spatial memory and learning (Jurdak et al., 2008).  
Although we were interested in the difference between the severity of cognitive 
deficits between the two diets at different time points after stroke, we were unable to 
observe any differences between these diet groups at 7 and 11 weeks. It is important to 
note that both the Y-maze and the NO task have a floor effect, meaning that the percent 
alternation or percent of NO contacts can only be lowered to a certain point. With this 
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issue of insensitivity at the lower end, any further cognitive deficits past a certain point 
will not be detected by these two behavioral tasks. Therefore, it is difficult to conclude 
from these behavioral tasks whether there was an actual difference in the severity of 
cognitive deficits between the two diet groups at 7 and 11 weeks after stroke. In the 
future, it may be useful to consider using more sensitive behavioral tasks. 
Since we observed delayed-cognitive deficits in HFD-fed animals and normal 
diet-fed animals at different time points after stroke, we were interested in testing if these 
were associated with increased ischemic brain tissue atrophy. Using the three different 
methods of measuring brain tissue atrophy, we did not detect any difference in brain 
atrophy between HFD-fed animals and normal diet-fed animals 11 weeks after stroke. 
This is not altogether unexpected, since we did not see differences in cognitive deficits in 
HFD-fed and normal diet-fed animals at 11 weeks after stroke, the endpoint of the 
experiment at which we analyzed brain atrophy. Unfortunately, due to the limitations of 
our experimental design we were unable to analyze brain atrophy at the earlier time 
points, such as 4 and 7 weeks, when we did observe differences in cognitive deficit 
between the two diet groups. It is possible that the degree of brain atrophy is in fact 
greater at 1, 4, and 7 weeks after stroke in HFD-fed animals, associated with earlier onset 
of cognitive deficits. In the future, it may be useful to utilize a longitudinal measure of 
infarct size, such as MRI, over time during these different time points after stroke. This 
would allow us to analyze the relationship between the infarct size and cognitive 
performance from the same time points. 
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To characterize the neuroinflammatory response after stroke in the chronic phase 
in HFD-fed and normal diet-fed animals, we measured the extent of 
microgliosis/infiltration of monocyte-derived macrophages (MDMs) and astrogliosis in 
the peri-infarct area after stroke. Although a less inclusive and more inclusive threshold 
can qualitatively give us a percent area covered by cell bodies or reactive/activated cells, 
respectively, it is limited in that it cannot give us an exact cell count. Using less inclusive 
thresholding, we found that HFD-fed animals but not normal diet-fed animals have 
increased astrogliosis compared to the Control animals 11 weeks after stroke. However, 
both HFD-fed and normal diet-fed animals had increased astrogliosis at this time point 
using a more inclusive thresholding. The difference between our findings in the normal-
diet group from using two thresholding techniques suggest that although the numbers of 
astrocytes in normal diet-fed animals are similar to the numbers found in Control animals 
at 11 weeks after stroke, the astrocytes in normal diet-animals adopt a more reactive 
phenotype compared to the astrocytes in Control animals at 11 weeks after stroke. On the 
other hand, our findings from the HFD-fed group suggest that there are significantly more 
astrocytes and that these adapt a more reactive phenotype compared to Control animals 
11 weeks after stroke. 
Our assessment of microgliosis found that normal diet-fed animals did not have 
increased microglia/MDM reactivity compared to Control animals 11 weeks after stroke. 
On the other hand, we demonstrated that HFD-fed animals had increased microgliosis 
compared to Control animals 11 weeks after stroke, regardless of the thresholding 
technique. These results suggest that HFD led to increased numbers of microglia/MDMs 
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that adapt a reactive phenotype at 11 weeks after stroke, and that the number of 
microglia/MDMs and their morphologies in normal diet-fed animals resemble what is 
seen before stroke.  
Overall, we demonstrated that HFD animals persistently have more astrogliosis 
and microgliosis in the peri-infarct area even at such a late time point after stroke. It is 
possible that microglia and astrocytes that have migrated to the peri-infarct area and 
proliferated during the acute phase continued to reside there even during the chronic 
phase after stroke. On the other hand, we showed that the neuroinflammatory response in 
normal diet-fed animals may just be limited to astrogliosis at 11 weeks after stroke. 
Although studies show that astrocytes form a glial scar after stroke, which continues to 
remodel and persist in the chronic phase and beyond (Burda & Sofroniew, 2014), we 
were not able to assess if there were any differences in in glial scarring between the two 
diet groups at 11 weeks after stroke since we only imaged the peri-infarct area for each 
animal. In the future, we would like to image the stroke border, which would allow us to 
assess glial scarring. 
We did notice that three animals from the dMCAO-HFD group consistently had 
relatively darker CD68 and GFAP staining compared to the tissue sections seen in 
animals from the same group, and that this darker staining resulted in high levels of 
detected CD68 and GFAP coverage in the per-infarct area in these three animals. We 
were unsure whether this relatively darker staining compared to those found in animals of 
the same group is a real biological difference and can be explained by biological 
variability, or if this difference is due to errors in processing of the tissue such as 
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ineffective perfusion of the brain or uneven immunostaining of the tissue sections. To 
resolve this issue, we plan to repeat the immunostaining to see if we can replicate these 
findings. 
It is also worthy to discuss our finding that there were no differences in the GFAP 
and CD68 coverage using both inclusive and less inclusive thresholding between the 
HFD-fed animals that underwent sham and Control animals. This result suggests that diet 
alone cannot significantly change the degree of activation, proliferation, and/or migration 
of astrocytes and microglia. However, there is literature citing that diet-induced obesity 
leads to increased microglial proliferation in specific areas of the brain like the corpus 
callosum (Freeman, Haley-Zitlin, Stevens, & Granholm, 2011; Nguyen et al., 2014) and 
that astrogliosis can occur in other parts of the brain like the frontal cortex, parietal 
cortex, and hippocampus (Tomassoni et al., 2013). Again, the differences with our 
findings with the literature may be due to the differences in the methods of obesity 
induction and the areas in the brain that were analyzed. For example, the study by 
Freeman et al. (2011) found increased microgliosis in the hippocampus in diet-induced 
obese rats (Freeman et al., 2011), whereas we examined the cortex in a mouse model 
instead. This is consistent with recent findings in our laboratory, where we discovered 
minimal cortical gene changes between HFD and normal diet-fed animals prior to stroke, 
as measured by RNA sequencing (Peterson & Buckwalter, unpublished). 
 Lastly, we were interested in seeing whether the weight and diet of animals 
affected brain atrophy and the degree of neuroinflammation after stroke, which we 
measured by the amount of astrogliosis and microgliosis. Contrary to our original 
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hypothesis, we found that heavier animals did not necessarily have increased brain 
atrophy or increased astrogliosis compared to lighter animals. However, since we did not 
find significant differences in brain atrophy and astrogliosis between HFD-fed animals 
and normal diet-fed animals 11 weeks after stroke, it was not surprising that weight did 
not affect these two variables. One the other hand, we did find that the relationship 
between weight and the degree of microgliosis was significantly affected by diet 
condition. The HFD-fed animals that weighed more tended to also have more 
microgliosis compared to those HFD-fed animals that weighed less. However, this 
finding should be taken with caution. We noticed that the animals in the dMCAO-HFD 
group that had relatively darker CD68 staining compared to the animals in the same 
group happened to be the heavier ones in that group. Again, this result could be a true 
biological finding or could be due a coincidence where the darker staining due to 
ineffective tissue processing happened to occur with the tissues from heavier animals, 
therefore falsely driving the trend that we observed. This will be uncovered by future 
experiments. 
In conclusion, we found an earlier onset of cognitive deficit in animals fed HFD 
compared to animals fed normal diet. Although we did not show that stroke size or brain 
atrophy was increased with HFD at 11 weeks after stroke, we did find more persistent 
neuroinflammation in HFD-fed mice at this time point. To further validate our results 
from the brain atrophy analysis, we also plan to measure the ipsilateral hemisphere area 
as a percent of the contralateral hemisphere area as well as the ipsilateral cortical area as 
a percent of the contralateral cortical area for both the Sham-normal diet and Sham-HFD 
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groups. This will provide us with a control, allowing us to know if the findings in the 
dMCAO-HFD group and the dMCAO-normal diet group were real biological findings, or 
if these findings were due to errors in our techniques, such as uneven sectioning of the 
brains. We also plan to image and threshold the stroke border for GFAP of all animals 
since we noticed more intense GFAP staining in those areas. Measuring the percent of 
stroke border covered by GFAP can possibly give us a more accurate reflection of the 
degree of glial scar formation. As mentioned earlier, we plan to troubleshoot our protocol 
for the NO task so that our measurements may more accurately reflect exploratory 
behavior in mice. 
In the future, we would like to further examine the neuroinflammatory response in 
the chronic phase after ischemic stroke by looking at other immune cells including B-
cells, T-cells, and dendritic cells, which are all shown to be a part of a larger adaptive 
inflammatory response that detrimentally affects cognitive functioning during the chronic 
phase (Doyle et al., 2015).  Since Doyle et al.’s (2015) study also found T-cells and 
microglia/MDMs in certain areas of the thalamus, striatum, and internal capsule (Doyle et 
al., 2015), we would also like to see if we can also replicate these findings in our study to 
determine if the extent of adaptive and innate immune cell activity in these regions in the 
chronic phase after stroke differs between HFD-fed and normal diet-fed animals. Overall, 
we are interested in assessing whether the mechanisms of the responses of these other 
immune cells differ between HFD-fed animals and normal diet-fed animals and whether 
differences in immune responses correlate with and contribute to the cognitive deficits at 
the different time points we saw in this study.  
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